Article_ID,fixed,only_notes_mismatch,Covidence_ID,Name_data_entry,Parameter_type,Parameter_FromFigure,Method_from_supplement,Parameter value,Exponent,Parameter lower bound,Parameter upper bound,Inverse_param,Parameter unit,Parameter value type,Parameter statistical approach,Parameter uncertainty - single type,Parameter uncertainty - single value,Parameter uncertainty - type,Parameter uncertainty - lower value,Parameter uncertainty - upper value,Distribution_type,Distribution_par1_type,Distribution_par1_value,Distribution_par1_uncertainty,Distribution_par2_type,Distribution_par2_value,Distribution_par2_uncertainty,parameter_paired,Parameter 2 value type,Parameter 2 value,Parameter 2 lower bound,Parameter 2 upper bound,Exponent_2,Inverse_param_2,Parameter 2 unit,Method_2_from_supplement,Parameter 2 statistical approach,Parameter 2 uncertainty - single type,Parameter 2 uncertainty - single value,Parameter 2 uncertainty type,Parameter 2 uncertainty - lower value,Parameter 2 uncertainty - upper value,Distribution_2_type,Distribution_2_par1_type,Distribution_2_par1_value,Distribution_2_par1_uncertainty,Distribution_2_par2_type,Distribution_2_par2_value,Distribution_2_par2_uncertainty,Genome_site,Genomic_sequence_available,Method_R,R_pathway,parameter_hd_from,Other_delay_start,parameter_hd_to,Other_delay_end,CFR_IFR_numerator,CFR_IFR_denominator,CFR_IFR_Method,Case_definition,Riskfactor_outcome,Riskfactor_name,Riskfactor_occupation,Riskfactor_significant,Riskfactor_adjusted,Method_disaggregated,Method_disaggregated_only,Method_disaggregated_by,Population_sex,Population_sample_size,Population_sample_type,Population_group,Population_age_min,Population_age_max,Population_country,Population_location,parameter_context_location_type,Method_moment_value,Urban/Rural area,Data_available,parameter_notes,Population_study_start_day,Population_study_start_month,Population_study_start_year,Population_study_end_day,Population_study_end_month,Population_study_end_year,access_param_id,Pathogen,num_rows,matching
59,1,FALSE,1078,Amy Dighe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Comorbidity,Occupation",Healthcare,Significant,Not adjusted,No,NA,NA,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,Risk factor outcome was death amongst patients with MERS SARI - Table 1,NA,9,2012,NA,10,2015,059_011,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients. Disaggregation into survivors and non-survivors (extracted separately),NA,9,2012,NA,10,2015,059_002,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Comorbidity,Sex",NA,Not significant,Not adjusted,No,NA,NA,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,Risk factor outcome was death amongst patients with MERS SARI - Table 1,NA,9,2012,NA,10,2015,059_012,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset,Other,Invasive mechanical ventilation,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,NA,Hospital based,Other,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients. Median and IQR apply to the 85.2% of patients who received intubation (out of 330 total). Disaggregated into survivors and non-survivors (extracted separately).,NA,9,2012,NA,10,2015,059_003,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - time in care (length of stay),No,No,19,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,10,35,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients. This is the hospital stay overall (disaggregation into survivors and non survivors extracted separately),NA,9,2012,NA,10,2015,059_004,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - time in care (length of stay),No,No,16,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,10,26,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Length of hospital stay among MERS SARI patients who did not survive.,NA,9,2012,NA,10,2015,059_014,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - time in care (length of stay),No,No,33,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,14,67,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients who had survived at 90 days. Hospital stay amongst the subset of cases who survived.,NA,9,2012,NA,10,2015,059_005,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,37,NA,NA,NA,NA,Days,Median,Estimated parameter,NA,NA,CI95%,24,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Time for RNA clearance,Other,Time for RNA clearance,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Other,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Time to viral clearance in MERS SARI patients amongst non-survivors,NA,9,2012,NA,10,2015,141_011,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,9,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,16,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Length of ICU stay among MERS SARI non-survivors,NA,9,2012,NA,10,2015,059_015,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,10,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,18,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients. ICU length of stay overall  (disaggregation into survivors and non survivors extracted separately),NA,9,2012,NA,10,2015,059_006,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,67.6,NA,NA,NA,NA,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,223,330,Naive,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Table 3 - hospital mortality. Mortality rate during hospital stay among MERS SARI cases. (Case def is SARI cases with positive MERS-CoV PCR test),NA,9,2012,NA,10,2015,141_012,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,12,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,26.5,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients who survived. ICU stay amongst survivors only.,NA,9,2012,NA,10,2015,059_007,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Severity - case fatality rate (CFR),No,No,65.8,NA,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,217,330,Naive,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),cities,Unspecified,Urban area,Not available,Mortality rate during ICU stay among MERS SARI cases.,NA,9,2012,NA,10,2015,059_017,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Human delay - other human delay (go to section),No,No,19,NA,NA,NA,No,Days,Median,Estimated parameter,NA,NA,CI95%,16,24,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,First positive RT-PCR test,Other,viral RNA clearance,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Population is MERS SARI patients who survived. Refers to clearance in respiratory samples. Kaplan Meier curve used to estimate.  pg 1689 text,NA,9,2012,NA,10,2015,059_008,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Age,Comorbidity,Occupation,Sex",Healthcare,Significant,Not adjusted,No,NA,NA,Both,555,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,"Population is patients with SARI. Comorbidities that were significant were: Any comorbidity, Chronic cardiac disease, Chronic pulmonary disease, Chronic neurological disease. HCWs and also Healthcare associated non HCWs were significant. Age was still significant when excluding healthcare workers. Table 1",NA,9,2012,NA,10,2015,059_009,MERS-CoV,1,0
59,1,FALSE,1078,Amy Dighe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Comorbidity,Other",NA,Not significant,Not adjusted,No,NA,NA,Both,555,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,"Population is SARI patients. Other is specifically BMI. Comorbidities that were insignificant were diabetes with chronic complications, chronic renal disease, Any malignancy, Liver disease, Immunosuppressant use, Rheumatological disease, and AIDS. Table 1",NA,9,2012,NA,10,2015,059_010,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,5,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,8,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Seeking Care,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Onset to emergency department visit,NA,9,2012,NA,10,2015,141_001,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,4,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,7.5,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Seeking Care,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,MERS non-survivors,NA,9,2012,NA,10,2015,141_004,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,5,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,8,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Seeking Care,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,MERS Survivors,NA,9,2012,NA,10,2015,141_007,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,MERS non-survivors,NA,9,2012,NA,10,2015,141_005,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),NA,NA,6,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,4,9,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Survivors,NA,9,2012,NA,10,2015,141_008,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,Intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Other,Both,217,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,MERS non-survivors,NA,9,2012,NA,10,2015,141_006,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),NA,NA,8,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,Intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,113,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,ICUs in 14 referral hospitals in 5 cities (see supplement),multiple cities,Unspecified,Urban area,Not available,Survivors,NA,9,2012,NA,10,2015,141_009,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Risk factors,No,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Comorbidity",NA,Significant,Adjusted,Yes,NA,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,aOR for all MERS SARI - table S4,NA,9,2012,NA,10,2015,141_019,MERS-CoV,1,0
141,1,FALSE,1078,Gina Cuomo-Dannenburg,Risk factors,No,Yes,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Comorbidity,NA,Not significant,Adjusted,Yes,Yes,Other,Both,330,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,14 ICUs across 5 cities,multiple cities,Unspecified,Urban area,Not available,"Table S4 - disaggregated by comorbidity. Some significant, others not significant, all adjusted. Outcome = 90 day mortality",NA,9,2012,NA,10,2015,141_020,MERS-CoV,1,0
99,1,FALSE,1461,Victoria Cox,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Hospitalisation,Other",NA,Significant,Not adjusted,No,NA,NA,Unspecified,22,Mixed settings,Mixed groups,NA,NA,"Algeria,Austria,China,Egypt,France,Greece,Italy,Malaysia,Netherlands,Philippines,Republic of Korea,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,Start outbreak,Unspecified,Yes - as an attachment,"Risk factor was for presence of secondary cases after 1 importation event (n=5 importations). The risk of secondary transmission following importation increased with the time to case isolation or death (OR = 1.7 p = 0.04) and more precisely with the duration of hospitalization (OR = 1.7, p = 0.02).",1,9,2012,31,7,2015,099_001,MERS-CoV,1,0
99,1,FALSE,1461,Victoria Cox,Risk factors,No,No,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Not significant,Not adjusted,No,NA,NA,Unspecified,22,Mixed settings,Mixed groups,NA,NA,"Algeria,Austria,China,Egypt,France,Greece,Italy,Malaysia,Netherlands,Philippines,Republic of Korea,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,Start outbreak,Unspecified,Yes - as an attachment,Risk factor was for presence of secondary cases after 1 importation event (n=5 importations). table 2,1,9,2012,31,7,2015,099_003,MERS-CoV,1,0
99,1,FALSE,1461,Victoria Cox,Human delay - other human delay (go to section),No,No,2.33,NA,NA,NA,No,Days,Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hospitalisation,Other,Isolation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Unspecified,NA,Mixed settings,Mixed groups,NA,NA,"Algeria,Egypt,Germany,Greece,Italy,Netherlands,Philippines,Thailand,United States of America",NA,NA,Start outbreak,Unspecified,Yes - as an attachment,"Delay from isolation to hospitalisation. Given a central value +/- some error, but this is unextracted because it is not explained. This value is for when ""attention was higher"" but this term is undefined. See pg 6 at the bottom.",1,9,2012,31,7,2015,31415,MERS-CoV,1,0
99,1,FALSE,1461,Victoria Cox,Human delay - other human delay (go to section),No,No,6.44,NA,NA,NA,No,Days,Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hospitalisation,Other,Isolation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Unspecified,NA,Mixed settings,Mixed groups,NA,NA,"Algeria,Egypt,Germany,Greece,Italy,Netherlands,Philippines,Thailand,United States of America",NA,NA,Start outbreak,Unspecified,Yes - as an attachment,"Delay from isolation to hospitalisation. Given a central value +/- some error, but this is unextracted because it is not explained. This value is for when ""attention was lower"" but this term is undefined. See pg 6 at the bottom.",1,9,2012,31,7,2015,099_002,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,4,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,7,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Other,emergency room,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated data: Patients who did not receive corticosteroid therapy with mean population age of 55.3 years (SD 17.3 years). Table 1,NA,9,2012,NA,10,2015,035_010,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - time in care (length of stay),No,No,12.5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,8,23,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,ICU length of stay. Disaggregated data: Patients who received corticosteroid therapy with mean population age of 57.8 years (SD 17.2 years). Table 3,NA,9,2012,NA,10,2015,035_001,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - time in care (length of stay),No,No,15,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,8,30,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Hospital length of stay.  Disaggregated data: Patients who did not receive corticosteroid therapy with mean population age of 55.3 years (SD 17.3 years). Table 3,NA,9,2012,NA,10,2015,035_009,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,8,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,emergency room,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,"Disaggregated data: Patients who received corticosteroid therapy with mean population age of 57.8 years (SD 17.2 years). table 1 - disaggregated by treatment received, onset > care seeking. steroid group",NA,9,2012,NA,10,2015,035_003,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,6.5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,4,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated data: Patients who did not receive corticosteroid therapy with mean population age of 55.3 years (SD 17.3 years). table 1 - disaggregated by treatment received. non-steroid group,NA,9,2012,NA,10,2015,035_011,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated data: Patients who did not receive corticosteroid therapy with mean population age of 55.3 years (SD 17.3 years). table 1 - disaggregated by treatment received. non-steroid group,NA,9,2012,NA,10,2015,035_012,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,12,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated data: Patients who received corticosteroid therapy with mean population age of 57.8 years (SD 17.2 years). table 1 - disaggregated by treatment received. steroid subgroup,NA,9,2012,NA,10,2015,035_004,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,6,12,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated data: Patients who received corticosteroid therapy with mean population age of 57.8 years (SD 17.2 years).,NA,9,2012,NA,10,2015,035_005,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Risk factors,No,No,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,NA,Significant,Adjusted,Yes,Yes,"Method, Other",Both,291,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals (see supplement). Same patients as other Arabi study,tertiary care hospitals,Unspecified,Unspecified,Not available,Receiving corticosteroid therapy was associated with higher 90-day mortality for both methods of multivariate logistic regression and Cox proportional hazards regression. Table 4,NA,9,2012,NA,10,2015,035_013,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,NA,Not significant,Adjusted,Yes,Yes,"Method, Other",Both,291,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals (see supplement). Same patients as other Arabi study,tertiary care hospitals,Unspecified,Unspecified,Not available,Receiving corticosteroid therapy was not associated with higher 90-day mortality for marginal structural model. Cox proportional hazards regression accounting for timevarying exposure. Table 4,NA,9,2012,NA,10,2015,035_014,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Significant,Adjusted,Yes,Yes,"Method, Other",Both,291,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals (see supplement). Same patients as other Arabi study,tertiary care hospitals,Unspecified,Unspecified,Not available,"Significant association of corticosteroid therapy with a delay in time to MERS-CoV RNA clearance for marginal structural Cox proportional hazards modelling method. Table 4 -- multiple methods, some significant some not, also different directions of aOR",NA,9,2012,NA,10,2015,164_024,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Not significant,Adjusted,Yes,Yes,"Method, Other",Both,291,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals (see supplement). Same patients as other Arabi study,tertiary care hospitals,Unspecified,Unspecified,Not available,No significant association between receiving corticosteroid therapy with the time to MERS-CoV RNA clearance for Cox proportional hazard regression.,NA,9,2012,NA,10,2015,035_015,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,75.5,NA,NA,NA,NA,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,114,151,Naive,Clinically diagnosed/symptomatic,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Not available,Patients who received steroids. ICU mortality. case = hospitalised with confirmed MERS by PCR. Table 3,NA,9,2012,NA,10,2015,164_011,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,77.5,NA,NA,NA,NA,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,117,151,Naive,Clinically diagnosed/symptomatic,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Not available,Patients who received steroids. Hospital mortality. case = hospitalised with confirmed MERS by PCR. Table 3,NA,9,2012,NA,10,2015,164_012,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),NA,NA,56.3,NA,NA,NA,NA,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,89,158,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Not available,Patients who didn't receive steroids. ICU mortality. case = hospitalised with confirmed MERS by PCR. Table 3,NA,9,2012,NA,10,2015,164_013,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,58.2,NA,NA,NA,NA,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,92,158,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Not available,Patients who didn't receive steroids. Hospital mortality. case = hospitalised with confirmed MERS by PCR. Table 3,NA,9,2012,NA,10,2015,164_014,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,13,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,158,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,ICU length of stay.  Disaggregated data: Patients who did not receive corticosteroid therapy with mean population age of 55.3 years (SD 17.3 years).,NA,9,2012,NA,10,2015,035_008,MERS-CoV,1,0
35,1,FALSE,1466,Alba Halliday,Human delay - time in care (length of stay),No,No,21,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,13,38,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Hospital stay length. Disaggregated data: Patients who received corticosteroid therapy with mean population age of 57.8 years (SD 17.2 years). Table 3,NA,9,2012,NA,10,2015,035_002,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,10,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,7,17,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of illness,Other,Corticosteroid initiation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,From 151 patients receiving steroid treatment - table 2,NA,9,2012,NA,10,2015,164_001,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,3,15,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Hospital admission,Other,Corticosteroid initiation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,table 2,NA,9,2012,NA,10,2015,164_002,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,3,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,1,7,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ICU Admission,Other,Corticosteroid initiation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,table 2,NA,9,2012,NA,10,2015,164_003,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),No,No,3,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,1,7,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of ventilation,Other,Corticosteroid initiation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,Both,151,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,table 2,NA,9,2012,NA,10,2015,164_004,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),NA,NA,17,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,7,34,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Time to RNA clearance,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,Both,31,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated by treatment. Did not receive corticosteroids. Data from 31 of 104 patients with repeated PCR testing. Details in paper. Table 3,NA,9,2012,NA,10,2015,164_020,MERS-CoV,1,0
164,1,FALSE,1466,Gina Cuomo-Dannenburg,Human delay - other human delay (go to section),NA,NA,21,NA,NA,NA,NA,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,10,31,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Time to RNA clearance,Other,Time to RNA clearance,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,NA,Both,34,Hospital based,Other,NA,NA,Saudi Arabia,14 participating hospitals,tertiary care hospitals,Unspecified,Unspecified,Not available,Disaggregated by treatment. Received corticosteroids. Data from 34 of 99 patients with repeated PCR testing. Details in paper. Table 3,NA,9,2012,NA,10,2015,164_019,MERS-CoV,1,0
160,1,FALSE,1549,Tini Garske,Reproduction number (Basic R0),No,No,NA,NA,0,6.9,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Other,Unspecified,182,Other,Other,NA,NA,Republic of Korea,Republic of Korea,country,Post outbreak,Unspecified,Yes - on another platform,"The parameter is the type-specific reproduction number from a 2x2 next generation matrix. Cases were classified as those who visited multiple healthcare facilities vs others. Case definition is all lab-confirmed cases recorded in this outbreak. The source of infection was available for 169 out of 185 reported cases, the likely infector was inferred based on timing of symptom onset for all but 3 cases (including the index case), and this analysis is based on the resulting network of 182 case pairs. Note that the upper value of R0 is high, but this applies only the the minority of cases that visited multiple healthcare facilities. The overall R0 of the outbreak is reported as 1.0 in the abstract (this is a somewhat trivial result as it is a closed outbreak which gives an R0 =1-1/N).",11,5,2015,31,8,2015,160_001,MERS-CoV,1,0
160,1,FALSE,1549,Tini Garske,Reproduction number (Basic R0),No,No,NA,NA,0,6.5,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,169,Other,Other,NA,NA,Republic of Korea,Republic of Korea,country,Post outbreak,Unspecified,Yes - on another platform,"The parameter is the type-specific reproduction number from a 2x2 next generation matrix. Cases were classified as those who visited multiple healthcare facilities vs others. Case definition is all lab-confirmed cases recorded in this outbreak. The source of infection was available for 169 out of 185 reported cases, and this analysis is based on these. Note that the  upper value of R0 is high, but this applies only the the minority of cases that visited multiple healthcare facilities. The overall R0 of the outbreak is reported as 1.0 in the abstract (this is a somewhat trivial result as it is a closed outbreak which gives an R0 =1-1/N).",11,5,2015,31,8,2015,160_002,MERS-CoV,1,0
160,1,FALSE,1549,Tini Garske,"Reproduction number (Effective, Re) - Human",No,No,NA,NA,0.2,4.4,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Time,Unspecified,182,Other,Other,NA,NA,Republic of Korea,Republic of Korea,country,Post outbreak,Unspecified,Yes - on another platform,The parameter is the Re of the superspreaders only (5 out of 185 cases were identified as superspreaders that were responsible for the vase majority of transmissions). This does not reflect the overall Rt across the whole population.,11,5,2015,31,8,2015,160_003,MERS-CoV,1,0
160,1,FALSE,1549,Tini Garske,Human delay - other human delay (go to section),No,No,NA,NA,5.1,7.6,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Other,Unspecified,182,Other,Persons under investigation,NA,NA,Republic of Korea,Republic of Korea,country,Post outbreak,Unspecified,Yes - on another platform,"The population was split 2 ways: into those that did or didn't cause secondary transmission, and superspreaders vs non-superspreaders, and the mean delay was given for each of the 2 subgroups, for each split: 4 values in total, and each person contributed to 2 of these. The differences between the groups were not significant for either split, and with this in mind I have extracted this according to the rule of 3.",11,5,2015,31,8,2015,160_004,MERS-CoV,1,0
168,1,FALSE,1568,Julia Halder,Seroprevalence - Unspecified,No,No,0,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,84,Unspecified,Other,NA,NA,NA,NA,NA,No,NA,NA,Both,104,Hospital based,Persons under investigation,NA,NA,Republic of Korea,"Gangdong, Seoul",NA,Mid outbreak,Unspecified,Unspecified,"Dialysis unit. 104 patients who could have contacted the index patient by staying in the dialysis unit (degree of potential contact grade 1-3), of which 84 consented to serology testing. Context age is of the 104",NA,NA,2015,NA,NA,NA,168_001,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Comorbidity,Occupation,Sex,Other",Healthcare,Not significant,Not adjusted,No,NA,NA,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,"risk factors for mortality in MERS-confirmed patients (not in general population), it's a prospective study so I am not sure with the survey dates and the dates I put in refer to when those patients were admitted to the hospitals",20,5,2015,18,7,2015,149_001,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Other",Unspecified,Significant,Not adjusted,No,NA,NA,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,"Old age, low albumin, altered mentality and high pneumonia severity index score at admission were risk factors for mortality. In addition, severe signs of inflammation at initial presentation (at hospital days 1-4), such as high inducible protein-10 (p=0.0013), monocyte chemoattractant protein-1 (p=0.0007) and interleukin 6 (p=0.0007) concentrations, and poor viral control (high viral load at hospital days 5-10, p<0.001) without adequate antibody titres (low antibody titre at hospital days 11-16, p=0.07) during the course of disease, were associated with mortality.",20,5,2015,18,7,2015,149_002,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - symptom onset>admission to care,No,No,5,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,4,10,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,"disaggregation available by survival, extracted from table 1",20,5,2015,18,7,2015,149_003,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - admission to care>discharge/recovery,No,No,13,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,10,17,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,"disaggregation available by survival, extracted from table 1",20,5,2015,18,7,2015,149_004,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - other human delay (go to section),No,No,8,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,4,14,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,hospital admission,Other,defervescence,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,"disaggregation available by survival, extracted from table 1",20,5,2015,18,7,2015,149_005,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - other human delay (go to section),No,No,0,0,0,4,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,hospital admission,Other,antiviral therapy,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,"disaggregation available by survival, extracted from table 1",20,5,2015,18,7,2015,149_006,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - other human delay (go to section),No,No,19,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,15,21,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Other,taking a sample which showed a negative result with RT-PCR for MERS-CoV,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,extracted from text,20,5,2015,18,7,2015,149_007,MERS-CoV,1,0
149,1,FALSE,1587,Yiran Wang,Human delay - other human delay (go to section),No,No,18,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,17,23,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Other,Positive conversion of immunofluorescent antibody (IFA) titre (â‰¥1:640) for MERS-CoV,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,30,Hospital based,Persons under investigation,NA,NA,Republic of Korea,3 MERS-designated hospitals,unspecified,Mid outbreak,Unspecified,Not available,extracted from text,20,5,2015,18,7,2015,149_008,MERS-CoV,1,0
92,1,FALSE,1613,Kieran Chopra,"Reproduction number (Effective, Re)",No,No,0.73,NA,NA,NA,No,No units,Maximum likelihood,Estimated parameter,NA,NA,CI95%,0.54,0.96,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,110,Unspecified,Unspecified,NA,NA,NA,Global,NA,Unspecified,Unspecified,Yes - on another platform,"Data is available, cited from another source",20,9,2012,1,8,2013,092_001,MERS-CoV,1,0
92,1,FALSE,1613,Kieran Chopra,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,Age,NA,Unspecified,Unspecified,No,NA,NA,Unspecified,110,Unspecified,Unspecified,NA,NA,NA,Global,NA,Unspecified,Unspecified,Yes - on another platform,"Relative susceptibility of over 20s: maximum likelihood 0.99; 95% CI (0.82, 1)",20,9,2012,1,8,2013,092_002,MERS-CoV,1,0
133,1,FALSE,1657,Joseph Hicks,Reproduction number (Basic R0) - Human,No,No,NA,NA,0.96,5.5,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,NA,Travel based,Persons under investigation,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Lebanon,Malaysia,Netherlands,Philippines,Republic of Korea,Spain,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,NA,NA,Yes - as an attachment,Estimated from importations; Uncertainty is given for each of the 14 R0 values individually. Each were produced from different model assumptions and distributions so cant quantify/summarise in this form; Data is available as a table in the paper,NA,NA,NA,NA,NA,NA,133_001,MERS-CoV,1,0
133,1,FALSE,1657,Joseph Hicks,"Reproduction number (Effective, Re) - Human",No,No,NA,NA,0.06,0.87,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,NA,Travel based,Persons under investigation,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Lebanon,Malaysia,Netherlands,Philippines,Republic of Korea,Spain,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,NA,NA,Yes - as an attachment,Data is available as a table in the paper,NA,NA,NA,NA,NA,NA,133_002,MERS-CoV,1,0
64,1,FALSE,1657,Megan Ruffle,Overdispersion,No,No,NA,NA,0.024,infinity,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,NA,Travel based,Persons under investigation,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Lebanon,Malaysia,Netherlands,Philippines,Republic of Korea,Spain,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,NA,NA,Yes - as an attachment,Overdispersion for effective reproduction number; Data is available as a table in the paper,NA,NA,NA,NA,NA,NA,064_004,MERS-CoV,1,0
64,1,FALSE,1657,Megan Ruffle,Overdispersion,No,No,NA,NA,0.019,0.078,No,No units,Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,NA,Travel based,Persons under investigation,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Lebanon,Malaysia,Netherlands,Philippines,Republic of Korea,Spain,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America",NA,NA,NA,NA,Yes - as an attachment,Overdispersion for basic reproduction number; Data is available as a table in the paper,NA,NA,NA,NA,NA,NA,064_002,MERS-CoV,1,0
49,1,FALSE,1677,Richard Sheppard,Reproduction number (Basic R0) - Human,No,No,0.91,NA,0,80,No,No units,Mean,Estimated parameter,NA,NA,CI95%,0.36,1.44,Negative-Binomial,Mean,0.91,yes (ONLY tick if this applies),NA,0.06,yes (ONLY tick if this applies),No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,"Occupation,Region,Method,Disease generation",Unspecified,NA,Hospital based,Mixed groups,NA,NA,"Republic of Korea,Saudi Arabia","South Korea; Al-Hasa, Kingdom of Saudi Arabia",NA,End outbreak,Unspecified,NA,"They fit a negative binomial distribution to secondary cases, across multiple disease generations, for Re which they call R0, and k. And also estimate R0 and Re empirically from trees and call both R0",1,4,2013,5,7,2015,049_001,MERS-CoV,1,0
49,1,FALSE,1677,Richard Sheppard,Overdispersion,No,No,0.06,NA,NA,NA,No,Unspecified,Unspecified,Estimated parameter,NA,NA,CI95%,0.03,0.09,Negative-Binomial,Mean,0.91,yes (ONLY tick if this applies),NA,0.06,yes (ONLY tick if this applies),No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Hospital based,Mixed groups,NA,NA,"Republic of Korea,Saudi Arabia","South Korea; Al-Hasa, Kingdom of Saudi Arabia",NA,End outbreak,Unspecified,NA,They fit a negative binomial distribution to secondary cases.,1,4,2013,5,7,2015,049_002,MERS-CoV,1,0
66,1,FALSE,1678,Alba Halliday,Human delay - incubation period,No,No,6.1,NA,4.6,8.8,No,Days,Median,Observed sample statistic,NA,NA,CI95%,4.7,7.5,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Region,Other",Both,25,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Daejeon,City,Post outbreak,Urban area,Not available,"Incubation period estimated by using the most probable exposure method. Disaggregated by hospital (A&B) and method for estimating incubation period (5.6 [4.2,6.9]). 1 index case, 25 new.",NA,5,2015,NA,7,2015,066_001,MERS-CoV,1,0
36,1,FALSE,1678,Richard Sheppard,Attack rate,No,No,3.7,NA,0,100,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Age,Level of exposure,Occupation,Sex,Other",Both,672,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Daejeon,City,Post outbreak,Urban area,Not available,"Attack rate among all exposed persons (25/672). Disaggregated by occupation (Nurse, Doctor & other), same ward & other ward, caregiver & patients",NA,5,2015,NA,7,2015,036_002,MERS-CoV,1,0
36,1,FALSE,1678,Richard Sheppard,Severity - case fatality rate (CFR),No,No,44,NA,0,83.3,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,25,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,Yes,"Region,Symptoms",Both,25,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Daejeon,City,Post outbreak,Urban area,Not available,Disaggregated by hospital (A&B) and concurrent conditions (pulmonary&non-pulmonary/none),NA,5,2015,NA,7,2015,036_003,MERS-CoV,1,0
36,1,FALSE,1678,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Age,Occupation,Sex,Other",Healthcare,Not significant,Not adjusted,Yes,No,"Level of exposure,Region,Other",Both,672,Hospital based,Mixed groups,NA,NA,Republic of Korea,Daejeon,City,Post outbreak,Urban area,Yes - on another platform,NA,NA,NA,2015,NA,NA,2015,036_004,MERS-CoV,1,0
56,1,FALSE,1683,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Comorbidity,Occupation,Sex",Healthcare,Not significant,Not adjusted,No,NA,NA,Both,186,Hospital based,Persons with symptoms,NA,NA,Republic of Korea,NA,NA,Post outbreak,Unspecified,Unspecified,The outcome is observed secondary infections. Other risk factor: recovered vs deceased infector > secondary infection,11,5,2015,NA,7,2015,056_001,MERS-CoV,1,0
56,1,FALSE,1683,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Significant,Not adjusted,No,NA,NA,Both,186,Hospital based,Persons with symptoms,NA,NA,Republic of Korea,NA,NA,Post outbreak,Unspecified,Unspecified,"The outcome is observed secondary infections, significant risk factor is outcome, where those that died had greater risk of causing secondary infections..",11,5,2015,NA,7,2015,056_002,MERS-CoV,1,0
56,1,FALSE,1683,Richard Sheppard,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Comorbidity,Occupation,Sex",Healthcare,Not significant,Adjusted,No,NA,NA,Both,186,Hospital based,Persons with symptoms,NA,NA,Republic of Korea,NA,NA,Post outbreak,Unspecified,Unspecified,The outcome is observed secondary infections. Other risk factor: recovered vs deceased infector > secondary infection,11,5,2015,NA,7,2015,056_003,MERS-CoV,1,0
56,1,FALSE,1683,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Significant,Adjusted,No,NA,NA,Both,186,Hospital based,Persons with symptoms,NA,NA,Republic of Korea,NA,NA,Post outbreak,Unspecified,Unspecified,"The outcome is observed secondary infections, significant risk factor is outcome, where those that died had greater risk of causing secondary infections..",11,5,2015,NA,7,2015,056_004,MERS-CoV,1,0
26,1,FALSE,1687,Tini Garske,Secondary attack rate,No,No,42,-4,3,75,No,NA,Unspecified,Observed sample statistic,NA,NA,CI95%,33,54,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Time,Unspecified,15831,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh City,emergency room in a large tertiary hospital,Post outbreak,Unspecified,Unspecified,NA,11,7,2015,26,8,2015,026_001,MERS-CoV,1,0
26,1,FALSE,1687,Tini Garske,Severity - proportion of asymptomatic cases,No,No,33,NA,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,43,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh City,emergency room in a large tertiary hospital,Post outbreak,Unspecified,Unspecified,"it seems they did the math wrong: 25 symptomatic + 18 asymptomatic cases = 43 cases, 18/43 = 42% asymptomatic, vs the 33% given in the paper.",11,7,2015,26,8,2015,026_002,MERS-CoV,1,0
58,1,FALSE,1687,Richard Sheppard,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,No,Days,Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,48,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh City,emergency room in a large tertiary hospital,Post outbreak,Unspecified,Unspecified,"There is another delay from a later time period, but this delay just has a single sample.",11,7,2015,26,7,2015,058_002,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Recovery,"Occupation,Other",Healthcare,Significant,Unspecified,NA,NA,NA,Both,96,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,NA,NA,6,2015,NA,9,2015,045_003,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),"Occupation,Other",Healthcare,Not significant,Unspecified,NA,NA,NA,Both,96,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,"The risk factor outcome was death between groups. Unsure what ""in general population"" is adding.",NA,6,2015,NA,9,2015,045_005,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Occupation,Other",Healthcare,Significant,Unspecified,No,NA,NA,Both,96,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,"The risk factor outcome was death between groups. Unsure what ""in general population"" is adding.",NA,6,2015,NA,9,2015,045_004,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Occupation,Other",Healthcare,Not significant,Unspecified,NA,NA,NA,Both,NA,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,Other non significant risk factors include duration of stay in hospital and ICU and a subset of symptoms.,NA,6,2015,NA,9,2015,045_006,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Occupation,Other",Healthcare,Significant,Unspecified,NA,NA,NA,Both,130,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,"Other significant risk factors is ""any symptoms""",NA,6,2015,NA,9,2015,045_007,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Human delay - time in care (length of stay),No,No,NA,NA,20.5,23.5,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Level of exposure,Both,96,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,NA,NA,6,2015,NA,9,2015,045_008,MERS-CoV,1,0
45,1,FALSE,1700,Richard Sheppard,Human delay - other human delay (go to section),No,No,NA,NA,8,22,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ICU admission,Other,End of ICU stay,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Level of exposure,Occupation",Both,96,Hospital based,Mixed groups,NA,NA,Saudi Arabia,"King Abdulaziz Medical City- Riyadh (KAMC-R), Ministry of National Guard Health Affairs",Hospital,Post outbreak,Urban area,Not available,NA,NA,6,2015,NA,9,2015,045_009,MERS-CoV,1,0
165,1,FALSE,1700,Julia Halder,Secondary attack rate,No,No,NA,NA,0.17,2.7,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Level of exposure,Occupation",Both,NA,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,King Abdulaziz Medical City-Riyadh,Hospital,Post outbreak,Urban area,Unspecified,"130 total cases (CAI, HAI, HAI-HCW); parameter 1 is 43 HCWs only from any hospital locations. Denominator unknown.",NA,6,2015,NA,9,2015,165_001,MERS-CoV,1,0
165,1,FALSE,1700,Julia Halder,Severity - case fatality rate (CFR),No,No,NA,NA,0,65.5,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,Other,NA,NA,NA,NA,NA,Yes,Yes,"Level of exposure,Occupation",Both,NA,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Abdulaziz Medical City-Riyadh,Hospital,Post outbreak,Urban area,Unspecified,Unclear if they have accounted for all known outcomes (i.e. right-censoring). Cases are both confirmed and probable (positive or inconclusive rt-PCR).,NA,6,2015,NA,9,2015,165_002,MERS-CoV,1,0
165,1,FALSE,1700,Julia Halder,Severity - proportion of symptomatic cases,No,No,NA,NA,58.1,100,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Level of exposure,Occupation,Symptoms",Both,NA,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Abdulaziz Medical City-Riyadh,Hospital,Post outbreak,Urban area,Unspecified,NA,NA,6,2015,NA,9,2015,165_003,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Human delay - incubation period,No,No,5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,13,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_001,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Human delay - other human delay (go to section),No,No,8,NA,7,9,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,0,15,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_002,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Attack rate,No,No,3.3,NA,NA,NA,No,Percentage (%),Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,"Level of exposure,Occupation,Other",Both,389,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,This is a secondary attack rate but paper states it as attack rate,18,5,2015,4,6,2015,029_003,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Severity - case fatality rate (CFR),No,No,16.7,NA,NA,NA,No,Percentage (%),Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,36,Unspecified,Confirmed,NA,NA,NA,NA,NA,Yes,No,"Age,Disease generation,Occupation,Sex,Symptoms,Other",Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_004,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Human delay - symptom onset>discharge/recovery,No,No,22.5,NA,17,26.5,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,9,41,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,"Disease generation,Occupation",Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_005,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Human delay - other human delay (go to section),No,No,NA,NA,12.5,17,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,5,30,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,MERS confirmation/test,Discharge from Care/Hospital,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Disease generation,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_006,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Human delay - symptom onset>death,No,No,12.5,NA,12.5,16.5,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,9,23,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_007,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Occupation,Sex,Other",NA,Not significant,Not adjusted,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_008,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Significant,Not adjusted,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_009,MERS-CoV,1,0
29,1,FALSE,1704,Christian Morgenstern,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Not significant,Not adjusted,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek St. Mary's Hospital,City/Hospital,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,029_010,MERS-CoV,1,0
55,1,FALSE,1704,Anh Pham,Attack rate,No,No,7.6,NA,NA,NA,No,Percentage (%),Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Other (paired),NA,4.7,18.6,NA,No,Percentage (%),No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Level of exposure,Both,263,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,055_001,MERS-CoV,1,0
55,1,FALSE,1704,Anh Pham,Attack rate,No,No,1.1,NA,NA,NA,No,Percentage (%),Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,5,12.5,NA,No,Percentage (%),No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Level of exposure,Both,277,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,NA,Urban area,Yes - as an attachment,NA,18,5,2015,4,6,2015,055_002,MERS-CoV,1,0
55,1,FALSE,1704,Anh Pham,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),Comorbidity,NA,Significant,Unspecified,NA,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek,City,Start outbreak,Urban area,Unspecified,NA,18,5,2015,4,6,2015,055_006,MERS-CoV,1,0
30,1,FALSE,1815,Christian Morgenstern,Seroprevalence - IgG,No,No,0,NA,NA,NA,No,Percentage (%),Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,285,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,285,Hospital based,Healthcare workers,NA,NA,Republic of Korea,National Medical Center,NA,Unspecified,NA,Not available,Paper doesn't specify date of serostudy,NA,NA,NA,NA,NA,NA,030_001,MERS-CoV,1,0
25,1,FALSE,1821,Hailin Feng,Human delay - incubation period,No,No,NA,NA,2,18,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Age,Sex,Symptoms,Other",Both,14,Hospital based,Persons with symptoms,39,82,Republic of Korea,Chungnam National University Hospital,Hospital,NA,Unspecified,Yes - as an attachment,Individual-level incubation periods are reported for all 14 patients treated at Chungnam National University Hospital in Table 1,7,6,2015,5,8,2015,025_001,MERS-CoV,1,0
25,1,FALSE,1821,Hailin Feng,Human delay - symptom onset>admission to care,No,Yes,NA,NA,2,12,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Age,Sex,Symptoms",Both,14,Hospital based,Persons with symptoms,39,82,Republic of Korea,Chungnam National University Hospital,Hospital,NA,Unspecified,Yes - as an attachment,Extracted from Supplementary Table S1 'Days after symptom onset' in section 'On admission',7,6,2015,5,8,2015,025_002,MERS-CoV,1,0
25,1,FALSE,1821,Hailin Feng,Human delay - time in care (length of stay),Yes,Yes,NA,NA,7,45,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Age,Sex,Symptoms",Both,14,Hospital based,Persons with symptoms,39,82,Republic of Korea,Chungnam National University Hospital,Hospital,NA,Unspecified,Not available,"This is extracted from Supplementary Fig S1, by counting difference between the day of hospital admission and the day of hospital discharge/death.",7,6,2015,5,8,2015,025_003,MERS-CoV,1,0
37,1,FALSE,1821,Christian Morgenstern,Severity - case fatality rate (CFR),No,No,NA,NA,NA,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,14,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,14,Hospital based,Persons under investigation,39,82,Republic of Korea,Chungnam National University Hospital,NA,NA,NA,Not available,NA,7,6,2015,5,8,2015,037_001,MERS-CoV,1,0
37,1,FALSE,1821,Christian Morgenstern,Risk factors,NA,NA,NA,NA,NA,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Significant,Unspecified,NA,NA,NA,Both,14,Hospital based,Persons under investigation,39,82,Republic of Korea,Chungnam National University Hospital,NA,NA,NA,Not available,Other = virological and immunological factors,7,6,2015,5,8,2015,037_002,MERS-CoV,1,0
37,1,FALSE,1821,Christian Morgenstern,Risk factors,NA,NA,NA,NA,NA,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Sex,NA,Not significant,Not adjusted,NA,NA,NA,Both,14,Hospital based,Persons under investigation,39,82,Republic of Korea,Chungnam National University Hospital,NA,NA,NA,Not available,NA,7,6,2015,5,8,2015,037_003,MERS-CoV,1,0
37,1,FALSE,1821,Christian Morgenstern,Human delay - symptom onset>death,No,No,NA,NA,NA,NA,NA,Weeks,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,NA,2,NA,No,Weeks,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,5,Hospital based,Persons under investigation,39,82,Republic of Korea,Chungnam National University Hospital,NA,NA,NA,Not available,NA,7,6,2015,5,8,2015,037_004,MERS-CoV,1,0
38,1,FALSE,1830,Christian Morgenstern,Overdispersion,No,No,82,NA,NA,NA,No,Max. nr. of cases superspreading (related to case),Other,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,92,Hospital based,Persons under investigation,NA,NA,Republic of Korea,"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul",NA,NA,NA,Not available,NA,20,5,2015,5,7,2015,038_001,MERS-CoV,1,0
38,1,FALSE,1830,Christian Morgenstern,Severity - proportion of asymptomatic cases,No,No,NA,NA,NA,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,92,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,92,Hospital based,Persons under investigation,NA,NA,Republic of Korea,"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul",NA,NA,NA,Not available,"Paper doesn't state the percentage value, so captured the proportion in the numerator/denominator boxes of the IFR section",20,5,2015,5,7,2015,038_002,MERS-CoV,1,0
31,1,FALSE,1843,Christian Morgenstern,Human delay - other human delay (go to section),No,No,5.5,NA,5,6,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,7,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Emergency room,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,NA,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities but didn't state which,NA,Unspecified,Urban area,Not available,NA,NA,9,2012,NA,9,2015,031_002,MERS-CoV,1,0
31,1,FALSE,1843,Christian Morgenstern,Human delay - other human delay (go to section),No,No,9,NA,5,9,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,5,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Other,Both,NA,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities but didn't state which,NA,Unspecified,Urban area,Not available,NA,NA,9,2012,NA,9,2015,031_003,MERS-CoV,1,0
31,1,FALSE,1843,Christian Morgenstern,Human delay - other human delay (go to section),No,No,9,NA,6.5,10,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,6,12,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Other,Both,NA,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities but didn't state which,NA,Unspecified,Urban area,Not available,NA,NA,9,2012,NA,9,2015,031_004,MERS-CoV,1,0
114,1,FALSE,1843,Kieran Chopra,Severity - case fatality rate (CFR),No,No,25,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,32,NA,Lab confirmed,NA,NA,NA,NA,NA,Yes,NA,Sex,Both,32,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities in KSA,NA,Unspecified,Urban area,Yes - as an attachment,"Study of CRITICALLY ILL HCWs, so CFR not representative. Lower quartile of ages 32; upper quartile 48; no minimum and maximum given.",NA,NA,2012,NA,NA,2015,114_001,MERS-CoV,1,0
114,1,FALSE,1843,Kieran Chopra,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Comorbidity,Sex",Healthcare,Unspecified,Not adjusted,No,NA,NA,Both,32,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities in KSA,NA,Unspecified,Urban area,Yes - as an attachment,"Effect of covariates on mortality in this *critically ill* population. covariates are age, sex, body mass index, comorbidities (diabetes with chronic complications, chronic cardiac disease, chronic renal disease, chronic pulmonary disease, any malignancy, any comorbidity), respiratory symptoms (various), gastrointestinal symptoms (vomiting, abdominal pain, diarrhoea, general), other symptoms and patient parameters (various, but not PaO2/FiO2 ratio or creatinine levels, which were reported as significant here. study of CRITICALLY ILL HCWs; CFR not necessarily representative of general population; lower quartile of sample 32; upper quartile of sample 48; lower quartile of dead people 33; upper quartile of dead people 58; lower quartile of survivors 32; upper quartile of survivors 47. sorry for the spam - this is my first extraction",NA,NA,2012,NA,NA,2015,114_002,MERS-CoV,1,0
114,1,FALSE,1843,Kieran Chopra,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,Healthcare,Significant,Not adjusted,NA,NA,NA,Both,32,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,14 hospitals across 5 cities in KSA,NA,Unspecified,Urban area,Yes - as an attachment,Effect of covariates on mortality in this *critically ill* population. covariates are PaO2/FiO2 ratio and creatinine levels. study of CRITICALLY ILL HCWs; CFR not necessarily representative of general population; lower quartile of sample 32; upper quartile of sample 48; lower quartile of dead people 33; upper quartile of dead people 58; lower quartile of survivors 32; upper quartile of survivors 47.,NA,NA,2012,NA,NA,2015,114_003,MERS-CoV,1,0
14,1,FALSE,1845,Thomas Rawson,Seroprevalence - Unspecified,No,No,0,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,285,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,285,Hospital based,Healthcare workers,NA,NA,Republic of Korea,'National Medical Center',clinic,Post outbreak,Unspecified,Not available,Sero test performed 'post outbreak' but very few details.,NA,NA,NA,NA,NA,NA,014_001,MERS-CoV,1,0
16,1,FALSE,1850,Thomas Rawson,Human delay - symptom onset>admission to care,No,No,3,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,7,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,11,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated). Admission is admission to hospital. Follow-up patients who needed intubation,NA,4,2014,NA,5,2014,016_001,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Admission to Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Other,Both,13,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated),NA,4,2014,NA,5,2014,105_002,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Human delay - other human delay (go to section),No,No,8,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,4,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Other,Intubation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,14,Hospital based,Persons with symptoms,23,79,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated),NA,4,2014,NA,5,2014,105_003,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Human delay - other human delay (go to section),No,No,16,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,32,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Time intubated,Other,Time extubated,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,14,Hospital based,Persons with symptoms,23,79,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated),NA,4,2014,NA,5,2014,105_004,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Human delay - time in care (length of stay),No,No,22,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,74,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,14,Hospital based,Persons with symptoms,23,79,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated). Length of stay refers to hospital.,NA,4,2014,NA,5,2014,105_005,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Human delay - other human delay (go to section),No,No,17,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,37,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,14,Hospital based,Persons with symptoms,23,79,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,Population is a severe subset of MERS patients (those with ARDS who were intubated),NA,4,2014,NA,5,2014,105_006,MERS-CoV,1,0
105,1,FALSE,1850,Amy Dighe,Severity - case fatality rate (CFR),No,No,64,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,14,Naive,Other,NA,NA,NA,NA,NA,No,NA,NA,Both,14,Hospital based,Persons with symptoms,23,79,Saudi Arabia,"King Faisal Specialist Hospital and Research Center, Jeddah","Hospital, City",Mid outbreak,Unspecified,Not available,"Re case definition, population is a severe subset of MERS patients (those with ARDS who were intubated)",NA,4,2014,NA,5,2014,105_007,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Severity - case fatality rate (CFR),No,No,22,0,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,35,159,Naive,Unspecified,NA,NA,NA,NA,NA,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,017_001,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Human delay - other human delay (go to section),No,No,10,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,8,12,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Start outbreak,Unspecified,Not available,NA,18,5,2015,24,5,2015,017_006,MERS-CoV,1,0
96,1,FALSE,1852,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,2,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,1,2,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,Delay measured during outbreak week 7 - dates and population determined from figure 1,22,6,2015,28,6,2015,096_003,MERS-CoV,1,0
96,1,FALSE,1852,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,13,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,17,25.3,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Diagnosis,Death,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,159,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,096_004,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Human delay - symptom onset>discharge/recovery,No,No,19,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,17,23,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,Delay measured for outbreak week 7 - dates and population (survivors only) extracted from figure 1,22,6,2015,28,6,2015,017_008,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Human delay - symptom onset>discharge/recovery,No,No,27,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,22,32,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Start outbreak,Unspecified,Not available,Delay measured for outbreak week 2 - dates and population (survivors only) extracted from figure 1,18,5,2015,24,5,2015,017_009,MERS-CoV,1,0
96,1,FALSE,1852,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,4,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,2,7,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,"Average over whole time period we assume, but not clear.",11,5,2015,15,7,2015,096_001,MERS-CoV,1,0
96,1,FALSE,1852,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,22,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,9,16.5,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Diagnosis,Discharge from Care/Hospital,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,Note that the reported median doesn't lie within the IQR,11,5,2015,15,7,2015,096_005,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity",NA,Significant,Not adjusted,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,017_002,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity",NA,Significant,Adjusted,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,017_003,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Occupation,Sex,Other",Healthcare,Not significant,Adjusted,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,017_004,MERS-CoV,1,0
17,1,FALSE,1852,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Occupation,Sex,Other",Healthcare,Not significant,Not adjusted,No,NA,NA,Both,159,Unspecified,Unspecified,16,87,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,NA,11,5,2015,15,7,2015,017_005,MERS-CoV,1,0
18,1,FALSE,1863,Thomas Rawson,Human delay - other human delay (go to section),No,No,15.6,NA,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,64,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to ICU,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,109,Hospital based,General population,NA,NA,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Not available,NA,NA,4,2014,NA,12,2015,018_003,MERS-CoV,1,0
18,1,FALSE,1863,Thomas Rawson,Human delay - time in care (length of stay),No,No,15.21,0,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,0.5,90,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,NA,Hospital based,General population,NA,NA,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Not available,NA,NA,4,2014,NA,12,2015,018_004,MERS-CoV,1,0
18,1,FALSE,1863,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Recovery,"Age,Comorbidity,Hospitalisation,Occupation,Other",Healthcare,Significant,Not adjusted,No,NA,NA,Both,249,Hospital based,General population,0.75,93,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Not available,NA,NA,4,2014,NA,12,2015,018_006,MERS-CoV,1,0
18,1,FALSE,1863,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Recovery,"Sex,Other",NA,Not significant,Not adjusted,No,NA,NA,Both,249,Hospital based,General population,0.75,93,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Not available,NA,NA,4,2014,NA,12,2015,018_007,MERS-CoV,1,0
18,1,FALSE,1863,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Recovery,"Age,Hospitalisation,Other",NA,Significant,Adjusted,No,NA,NA,Both,249,Hospital based,General population,0.75,93,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Not available,NA,NA,4,2014,NA,12,2015,018_008,MERS-CoV,1,0
94,1,FALSE,1863,Victoria Cox,Severity - case fatality rate (CFR),No,No,20.08,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,249,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,249,Hospital based,General population,0.75,93,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Unspecified,NA,NA,4,2014,NA,12,2015,094_001,MERS-CoV,1,0
94,1,FALSE,1863,Victoria Cox,Human delay - incubation period,No,No,6.27,0,NA,NA,No,Days,Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,14,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,18,Hospital based,General population,NA,NA,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Unspecified,NA,NA,4,2014,NA,12,2015,094_002,MERS-CoV,1,0
94,1,FALSE,1863,Victoria Cox,Human delay - other human delay (go to section),No,No,13.17,0,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,40,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Other,negative swab,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,167,Hospital based,General population,NA,NA,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Unspecified,NA,NA,4,2014,NA,12,2015,094_003,MERS-CoV,1,0
94,1,FALSE,1863,Victoria Cox,Severity - proportion of symptomatic cases,No,No,83.53,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,249,Hospital based,General population,0.75,93,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Unspecified,NA,NA,4,2014,NA,12,2015,094_004,MERS-CoV,1,0
94,1,FALSE,1863,Victoria Cox,Human delay - other human delay (go to section),No,No,18.48,0,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,0.5,104,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Mechanical ventilator start,Other,Mechanical ventilator end,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,76,Hospital based,General population,NA,NA,Saudi Arabia,Prince Mohamed Bin Abdulaziz Hospital (PMAH); Riyadh,hospital,Unspecified,Unspecified,Unspecified,NA,NA,4,2014,NA,12,2015,094_006,MERS-CoV,1,0
19,1,FALSE,1874,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Significant,Not adjusted,NA,NA,NA,Both,186,Hospital based,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,"z-test for age, chi-square test for region and visited hospital. Youngest death in 40-59 group, oldest in over 80 group.",6,5,2015,1,7,2015,019_001,MERS-CoV,1,0
19,1,FALSE,1874,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Sex,NA,Not significant,Not adjusted,No,NA,NA,Both,186,Hospital based,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,"chi-square test. Youngest death in 40-59 group, oldest in over 80 group.",6,5,2015,1,7,2015,019_002,MERS-CoV,1,0
19,1,FALSE,1874,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,Age,NA,Significant,Not adjusted,No,NA,NA,Both,186,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,z-test,6,5,2015,1,7,2015,019_003,MERS-CoV,1,0
19,1,FALSE,1874,Thomas Rawson,Reproduction number (Basic R0),No,No,5.3973,NA,NA,NA,No,No units,Central - unspecified,Estimated parameter,NA,NA,CI95%,4.6057,6.1888,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Next generation matrix,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do,",regions,Post outbreak,Unspecified,Not available,"Regions account for 80% of confirmed cases from four of twelve hospitals - other regions unspecified. 186 total from 06-05-2015 to 01-07-2015. Youngest case in 0-18 group, oldest in over 80 group.",6,5,2015,7,6,2015,019_004,MERS-CoV,1,0
19,1,FALSE,1874,Thomas Rawson,Reproduction number (Basic R0),No,No,0.1351,NA,NA,NA,No,No units,Central - unspecified,Estimated parameter,NA,NA,CI95%,0.0403,0.2562,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Next generation matrix,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,NA,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do,",regions,Post outbreak,Unspecified,Not available,"Regions account for 80% of confirmed cases from four of twelve hospitals - other regions unspecified. 186 total from 06-05-2015 to 01-07-2015. Youngest case in 0-18 group, oldest in over 80 group.",7,6,2015,1,7,2015,019_005,MERS-CoV,1,0
98,1,FALSE,1874,Alba Halliday,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Significant,Not adjusted,No,NA,NA,Both,186,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,outcome: number of cases by generation. Risk factors: Mortality & Region.,6,5,2015,1,7,2015,098_006,MERS-CoV,1,0
98,1,FALSE,1874,Alba Halliday,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Sex,NA,Not significant,Not adjusted,No,NA,NA,Both,186,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,outcome: number of cases by generation.,6,5,2015,1,7,2015,098_007,MERS-CoV,1,0
98,1,FALSE,1874,Alba Halliday,Severity - case fatality rate (CFR),No,No,NA,NA,NA,NA,No,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,186,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,Yes,Occupation; Sex; Age,Both,186,Unspecified,Unspecified,NA,NA,Republic of Korea,"Daejeon, Seoul, Gyeonggi-do",regions,Post outbreak,Unspecified,Not available,CFR health care workers - note that percentage doesn't match data.,6,5,2015,1,7,2015,098_008,MERS-CoV,1,0
72,1,FALSE,1883,David Jorgensen,Severity - case fatality rate (CFR),No,No,62,NA,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,16,Naive,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,16,Community based,Persons with symptoms,19,84,Saudi Arabia,tertiary care hospital,NA,Unspecified,Urban area,Yes - as an attachment,patients in a hospital setting but triangulated as community acquired infections. 'All case patients except 1 had comorbidities and/or immunocompromised status' but CFR was for all positive cases that presented in hospital. Patient data available in Table 3.,1,7,2013,31,1,2015,072_001,MERS-CoV,1,0
142,1,FALSE,1883,Patrick Doohan,Human delay - other human delay (go to section),No,No,21,NA,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,4,57,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset while in Hospital,Recovery/non-Infectiousness,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,16,Community based,Persons with symptoms,19,84,Saudi Arabia,tertiary care hospital,NA,Unspecified,Urban area,Yes - as an attachment,patients in a hospital setting but triangulated as community acquired infections. 'All case patients except 1 had comorbidities and/or immunocompromised status' but CFR was for all positive cases that presented in hospital. Patient data available in Table 3.,1,7,2013,31,1,2015,142_001,MERS-CoV,1,0
142,1,FALSE,1883,Patrick Doohan,Severity - proportion of symptomatic cases,No,No,NA,NA,NA,NA,NA,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,16,Naive,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,16,Community based,Persons with symptoms,19,84,Saudi Arabia,tertiary care hospital,NA,Unspecified,Urban area,Yes - as an attachment,patients in a hospital setting but triangulated as community acquired infections. 'All case patients except 1 had comorbidities and/or immunocompromised status' but CFR was for all positive cases that presented in hospital. Patient data available in Table 3.,1,7,2013,31,1,2015,142_002,MERS-CoV,1,0
65,1,FALSE,1891,Tini Garske,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Other",NA,Significant,Adjusted,NA,NA,NA,Both,186,Population based,Persons with symptoms,16,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,"outcome is mortality among confirmed cases. There are 7 significant risk factors: 1. age 2. dyspnoea (during entire disease course), 3. diabetes mellitus, 4. chronic lung disease, 5. systolic blood pressure below 90mm Hg at admission, 6. white blood cell count at admission > 10,000/mm^3, 7. treated with mechanical ventilation",NA,5,2015,NA,NA,2015,065_001,MERS-CoV,1,0
143,1,FALSE,1891,Patrick Doohan,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Occupation,Other",Healthcare,Significant,Not adjusted,NA,NA,NA,Both,186,Population based,Persons with symptoms,16,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,outcome is mortality among confirmed cases. Other RFs are various symptoms and medical tests,NA,5,2015,NA,NA,2015,143_006,MERS-CoV,1,0
143,1,FALSE,1891,Patrick Doohan,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Comorbidity,Sex,Other",NA,Not significant,Not adjusted,NA,NA,NA,Both,186,Population based,Persons with symptoms,16,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,outcome is mortality among confirmed cases. Other RFs are various symptoms and medical tests,NA,5,2015,NA,NA,2015,143_007,MERS-CoV,1,0
65,1,FALSE,1891,Tini Garske,Human delay - symptom onset>death,No,No,14,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,174,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,33,Population based,Persons with symptoms,49,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,the upper end of the range (174 days) may be dodgy as the also report that all 33 cases die within 28 days.,NA,5,2015,NA,NA,2015,065_003,MERS-CoV,1,0
65,1,FALSE,1891,Tini Garske,Human delay - symptom onset>discharge/recovery,No,No,21,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,7,187,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,153,Population based,Persons with symptoms,17,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,NA,NA,5,2015,NA,NA,2015,065_004,MERS-CoV,1,0
65,1,FALSE,1891,Tini Garske,Human delay - other human delay (go to section),No,No,17,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,4,45,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset,Other,Negative PCR Test (Sputum),NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,153,Population based,Persons with symptoms,17,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,NA,NA,5,2015,NA,NA,2015,065_005,MERS-CoV,1,0
65,1,FALSE,1891,Tini Garske,Human delay - other human delay (go to section),No,No,6,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,20,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,symptom onset,Other,initiation of antiviral treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,139,Population based,Persons with symptoms,NA,NA,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,"outcome is mortality among confirmed cases, risk factor is dyspnea at admission",NA,5,2015,NA,NA,2015,065_002,MERS-CoV,1,0
143,1,FALSE,1891,Patrick Doohan,Severity - proportion of asymptomatic cases,No,No,1.1,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,186,Naive,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,186,Population based,Persons with symptoms,16,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,NA,NA,5,2015,NA,NA,2015,143_004,MERS-CoV,1,0
143,1,FALSE,1891,Patrick Doohan,Severity - case fatality rate (CFR),No,No,20.4,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,38,186,Naive,Confirmed,NA,NA,NA,NA,NA,Yes,No,"Age,Occupation,Sex,Symptoms,Other",Both,186,Population based,Persons with symptoms,16,86,Republic of Korea,NA,NA,Post outbreak,Unspecified,Not available,NA,NA,5,2015,NA,NA,2015,143_005,MERS-CoV,1,0
162,1,FALSE,1904,Julia Halder,Reproduction number (Basic R0),No,No,0.75,NA,NA,NA,No,No units,Unspecified,Estimated parameter,NA,NA,CI95%,0.54,1.09,Negative-Binomial,Mean,0.75,yes (ONLY tick if this applies),NA,0.14,yes (ONLY tick if this applies),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,36,Unspecified,Unspecified,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Jordan,Kuwait,Lebanon,Malaysia,Netherlands,Oman,Philippines,Republic of Korea,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America,Yemen","All countries with importation events, excluding Saudi, Qatar, UAE",NA,Unspecified,Unspecified,Unspecified,"This was estimated by fitting a BP model to data on secondary case counts for different importation events, where sample size refers to number of importation events considered. This is full sample. Uses all 36 events. Data from other papers, unknown if directly available.",NA,NA,NA,NA,NA,NA,162_001,MERS-CoV,1,0
162,1,FALSE,1904,Julia Halder,Overdispersion,No,No,0.14,NA,NA,NA,No,No units,Unspecified,Estimated parameter,NA,NA,CI95%,0.06,0.32,Negative-Binomial,Mean,0.75,yes (ONLY tick if this applies),NA,0.14,yes (ONLY tick if this applies),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,36,Unspecified,Unspecified,NA,NA,"Algeria,Austria,China,Egypt,France,Germany,Greece,Iran (Islamic Republic of),Italy,Jordan,Kuwait,Lebanon,Malaysia,Netherlands,Oman,Philippines,Republic of Korea,Thailand,Tunisia,TÃ¼rkiye,United Kingdom of Great Britain and Northern Ireland,United States of America,Yemen","All countries with importation events, excluding Saudi, Qatar, UAE",NA,Unspecified,Unspecified,Unspecified,"This was estimated by fitting a BP model to data on secondary case counts for different importation events, where sample size refers to number of importation events considered. This is full sample. Uses all 36 events. Data from other papers, unknown if directly available.",NA,NA,NA,NA,NA,NA,162_002,MERS-CoV,1,0
162,1,FALSE,1904,Julia Halder,Reproduction number (Basic R0),No,No,0.81,NA,NA,NA,No,No units,Unspecified,Estimated parameter,NA,NA,CI95%,0.49,1.46,Negative-Binomial,Mean,0.81,yes (ONLY tick if this applies),NA,0.07,yes (ONLY tick if this applies),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,23,Unspecified,Unspecified,NA,NA,"Algeria,Austria,China,France,Germany,Greece,Italy,Malaysia,Netherlands,Philippines,Republic of Korea,Thailand,Tunisia,United Kingdom of Great Britain and Northern Ireland,United States of America","Subset of 15 countries. Table 1 says '23 countries', error.",NA,Unspecified,Unspecified,Unspecified,"This was estimated by fitting a BP model to data on secondary case counts for different importation events, where sample size refers to number of importation events considered. This is restricted sample that excludes Middle-East. Subset of non Middle East countries; 23 events; 208 cases. Data from other papers, unknown if actually available.",NA,NA,NA,NA,NA,NA,162_003,MERS-CoV,1,0
162,1,FALSE,1904,Julia Halder,Overdispersion,No,No,0.07,NA,NA,NA,No,No units,Unspecified,Estimated parameter,NA,NA,CI95%,0.02,0.21,Negative-Binomial,Mean,0.81,yes (ONLY tick if this applies),NA,0.07,yes (ONLY tick if this applies),NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,23,Unspecified,Unspecified,NA,NA,"Algeria,Austria,China,France,Germany,Greece,Italy,Malaysia,Netherlands,Philippines,Republic of Korea,Thailand,Tunisia,United Kingdom of Great Britain and Northern Ireland,United States of America","Subset of 15 countries. Table 1 says '23 countries', error.",NA,Unspecified,Unspecified,Unspecified,"This was estimated by fitting a BP model to data on secondary case counts for different importation events, where sample size refers to number of importation events considered. This is restricted sample that excludes Middle-East. Subset of non Middle East countries; 23 events; 208 cases. Data from other papers, unknown if actually available.",NA,NA,NA,NA,NA,NA,162_004,MERS-CoV,1,0
83,1,FALSE,1925,Yiran Wang,Secondary attack rate,No,No,23.1,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,26,Household based,Other,NA,NA,Saudi Arabia,Al-Ahssa,province,Unspecified,Unspecified,Unspecified,The index case had close contact with camels which were later tested positive for MERS. Group is household members of index case,20,4,2015,23,6,2015,083_001,MERS-CoV,1,0
83,1,FALSE,1925,Yiran Wang,Severity - case fatality rate (CFR),No,No,40.4,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,52,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,52,Mixed settings,Mixed groups,NA,NA,Saudi Arabia,Al-Ahssa,province,Unspecified,Unspecified,Unspecified,mixed groups in mixed settings (household and hospital),20,4,2015,23,6,2015,083_002,MERS-CoV,1,0
83,1,FALSE,1925,Yiran Wang,Severity - proportion of symptomatic cases,No,No,84.6,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,44,52,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,52,Mixed settings,Mixed groups,NA,NA,Saudi Arabia,Al-Ahssa,province,Unspecified,Unspecified,Unspecified,NA,20,4,2015,23,6,2015,083_003,MERS-CoV,1,0
83,1,FALSE,1925,Yiran Wang,Human delay - incubation period,No,No,6,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,44,Mixed settings,Mixed groups,NA,NA,Saudi Arabia,Al-Ahssa,province,Unspecified,Unspecified,Unspecified,The median incubation period was ABOUT 6 days.,20,4,2015,23,6,2015,083_004,MERS-CoV,1,0
83,1,FALSE,1925,Yiran Wang,Severity - proportion of asymptomatic cases,No,No,15.4,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,52,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,52,Mixed settings,Mixed groups,NA,NA,Saudi Arabia,Al-Ahssa,province,Unspecified,Unspecified,Unspecified,NA,20,4,2015,23,6,2015,083_005,MERS-CoV,1,0
85,1,FALSE,1933,Ruth McCabe,Human delay - symptom onset>admission to care,No,Yes,4.6,NA,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Standard Deviation,4.5,NA,NA,NA,NA,Days,Yes,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,Data was available for 31% of the cases,Hospital based,Persons under investigation,NA,NA,"Jordan,Kuwait,Oman,Qatar,Saudi Arabia,United Arab Emirates,Yemen",Middle East,"Country, Province",Mid outbreak,Unspecified,Yes - on another platform,Data are presented in graph in supp,NA,3,2012,NA,9,2014,085_001,MERS-CoV,1,0
85,1,FALSE,1933,Ruth McCabe,Human delay - other human delay (go to section),No,Yes,10.5,NA,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Standard Deviation,9.2,NA,NA,NA,No,Days,Yes,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Notification to WHO,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,Data was available for 49% of the cases.,Hospital based,Persons under investigation,NA,NA,"Jordan,Kuwait,Oman,Qatar,Saudi Arabia,United Arab Emirates,Yemen",Middle East,region,Unspecified,Unspecified,Yes - on another platform,Data are shown in figure in supp,NA,3,2012,NA,9,2014,085_002,MERS-CoV,1,0
85,1,FALSE,1933,Ruth McCabe,"Reproduction number (Effective, Re)",Yes,No,NA,NA,NA,NA,No,NA,NA,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Region, Method",Unspecified,NA,Hospital based,Persons under investigation,NA,NA,"Jordan,Kuwait,Oman,Qatar,Saudi Arabia,United Arab Emirates,Yemen",,,Mid outbreak,Unspecified,Yes - on another platform,Figure 2 presents estimates of R per region,NA,3,2012,NA,9,2014,085_003,MERS-CoV,1,0
85,1,FALSE,1933,Ruth McCabe,"Reproduction number (Effective, Re)",No,No,NA,NA,0.26,2.3,No,No units,Mean,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,,,Mid outbreak,Unspecified,Yes - on another platform,NA,NA,3,2012,NA,9,2014,085_004,MERS-CoV,1,0
85,1,FALSE,1933,Ruth McCabe,Relative contribution - human to human,No,No,75,NA,52,89,No,Percentage (%),Central - unspecified,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,"Region,Time",Unspecified,NA,Hospital based,Persons under investigation,NA,NA,"Jordan,Kuwait,Oman,Qatar,Saudi Arabia,United Arab Emirates,Yemen",Middle East,"Country, Province",Unspecified,Unspecified,Yes - on another platform,NA,NA,3,2012,NA,9,2014,085_005,MERS-CoV,1,0
87,1,FALSE,1943,Ruth McCabe,Severity - case fatality rate (CFR),No,NA,NA,NA,1.8,48.4,No,Percentage (%),Maximum likelihood,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Confirmed,NA,NA,NA,NA,NA,Yes,Yes,"Age,Time,Other",Both,185,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - on another platform,"Parameter is not ONLY reported in a figure but it is fully disaggregated in a figure. 'Other' is 'under treatment'. Uncertainty for highest risk group: 95% CI of (35.2-61.3%). Other uncertainties were not available, so I didn't enter this here.",NA,5,2015,NA,7,2015,087_004,MERS-CoV,1,0
126,1,FALSE,1943,Kieran Chopra,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Significant,Not adjusted,No,NA,NA,Both,185,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - on another platform,Context: whole outbreak. Data from WHO (published). Being aged over 60 and a 'patient under treatment' are the covariates,NA,5,2015,NA,7,2015,126_001,MERS-CoV,1,0
126,1,FALSE,1943,Kieran Chopra,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Sex,NA,Not significant,Not adjusted,No,NA,NA,Both,185,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - on another platform,NA,NA,5,2015,NA,7,2015,126_002,MERS-CoV,1,0
126,1,FALSE,1943,Kieran Chopra,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Unspecified,Adjusted,NA,NA,NA,Both,185,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - on another platform,"Age and being a 'patient in treatment' are the covariates considered. They are separately analysed in an unadjusted analysis. In the analysis, odds ratios are given but the paper doesn't specify whether they're significant. Could argue significance of the risk factors based on CIs",NA,5,2015,NA,7,2015,126_003,MERS-CoV,1,0
126,1,FALSE,1943,Kieran Chopra,Human delay - symptom onset>death,No,No,14.6,NA,NA,NA,No,Days,Mean,Estimated parameter,NA,NA,CI95%,11.5,19.5,NA,NA,NA,NA,NA,NA,NA,Yes,Standard Deviation,10.4,NA,NA,0,No,Days,No,Estimated parameter,NA,NA,CI95%,7.6,16.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,185,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - on another platform,NA,NA,5,2015,NA,7,2015,126_006,MERS-CoV,1,0
88,1,FALSE,1947,Ruth McCabe,Human delay - other human delay (go to section),No,No,13,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Isolation,Discharge from Care/Hospital,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,"No information given on how this was estimated, but the word ""estimated"" is used.",NA,5,2015,NA,7,2015,088_001,MERS-CoV,1,0
88,1,FALSE,1947,Ruth McCabe,"Reproduction number (Effective, Re)",Yes,No,NA,NA,NA,NA,No,No units,Unspecified,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,186,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,Mid outbreak,Unspecified,Not available,Plot of Rt without any uncertainty,NA,5,2015,NA,7,2015,088_002,MERS-CoV,1,0
107,1,FALSE,1958,Amy Dighe,Reproduction number (Basic R0),No,No,4.42,NA,NA,NA,No,No units,Central - unspecified,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,NA,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,Start outbreak,Unspecified,Not available,R0 estimated by calibrating transmission coefficients and using least-squares method to assess fit to data from before 9th June when authors say effective control measures were introduced (this is the time that the incidence of confirmed cases started to decline).,20,5,2015,8,6,2015,107_001,MERS-CoV,1,0
107,1,FALSE,1958,Amy Dighe,Reproduction number (Basic R0),No,No,0.385,NA,NA,NA,No,No units,Central - unspecified,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Method,Unspecified,NA,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,End outbreak,Unspecified,Not available,"Refered to as Rc, estimated using transmission coefficients from the start of the outbreak (model 1) and calibrating personal protection and isolation coefficients to fit the case data. Is stated to be a ""basic reproduction number"". Sensitivity analysis is the disaggregation.",9,6,2015,10,7,2015,107_002,MERS-CoV,1,0
138,1,FALSE,1959,Gemma Nedjati-Gilani,Human delay - incubation period,No,No,7,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,14,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,NA,Other,Both,17,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Yes - as an attachment,"individual-level data available in table 1. Cases are lab confirmed, and all lab confirmed were hospitalised irrespective of symptoms",NA,NA,2015,NA,NA,2015,138_001,MERS-CoV,1,0
69,1,FALSE,1959,Anne Cori,Human delay - other human delay (go to section),No,No,5,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,11,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Isolation unit,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,17,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Not available,"Cases are lab confirmed, and all lab confirmed were hospitalised irrespective of symptoms",NA,NA,2015,NA,NA,2015,069_002,MERS-CoV,1,0
138,1,FALSE,1959,Gemma Nedjati-Gilani,Human delay - symptom onset>discharge/recovery,No,No,21,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,12,142,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,17,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Yes - as an attachment,"Cases are lab confirmed, and all lab confirmed were hospitalised irrespective of symptoms. This is reported as delay to discharge; however based on values in the table, it also includes deaths",NA,NA,2015,NA,NA,2015,138_003,MERS-CoV,1,0
69,1,FALSE,1959,Anne Cori,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),Other,NA,Significant,Not adjusted,No,NA,NA,Both,17,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Not available,higher neutrophil count in week 1 among severe cases,NA,NA,2015,NA,NA,2015,069_004,MERS-CoV,1,0
138,1,FALSE,1959,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,8,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,6,12,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Oxygen supplementation,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,9,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Not available,NA,NA,NA,2015,NA,NA,2015,138_005,MERS-CoV,1,0
138,1,FALSE,1959,Gemma Nedjati-Gilani,Human delay - other human delay (go to section),No,No,11,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Other,Ventilation support,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,5,Hospital based,Persons under investigation,35,79,Republic of Korea,Seoul,City,Unspecified,Unspecified,Not available,NA,NA,NA,2015,NA,NA,2015,138_006,MERS-CoV,1,0
101,1,FALSE,1963,Victoria Cox,Severity - case fatality rate (CFR),No,No,43,0,NA,NA,No,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,143,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,143,Mixed settings,Persons under investigation,2,99,Saudi Arabia,NA,NA,Unspecified,Unspecified,Unspecified,NA,1,7,2015,31,8,2015,101_001,MERS-CoV,1,0
75,1,FALSE,1973,Anne Cori,Human delay - symptom onset>death,NA,NA,NA,NA,NA,NA,No,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,23,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,6,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Not available,NA,11,5,2015,24,6,2015,075_001,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Severity - case fatality rate (CFR),No,No,16.2,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,37,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,37,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Not available,"Single hospital; 1 index case, 20 patients, 12 relatives of patients, 3 hospital staff, 1 unrelated visitor.",11,5,2015,24,6,2015,115_001,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - incubation period,No,No,6,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,4,7,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,15,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,36,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Not available,NA,11,5,2015,24,6,2015,115_002,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - incubation period,No,No,4,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,4,6,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,25,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Not available,Secondary infection incubation period.,11,5,2015,24,6,2015,115_004,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - incubation period,No,No,6,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,6,8,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,11,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Not available,Tertiary infection incubation period,11,5,2015,24,6,2015,115_006,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - other human delay (go to section),No,No,6.5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,4,9,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,0,15,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,37,Hospital based,Persons under investigation,24,79,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Yes - as an attachment,individual level data in table,11,5,2015,24,6,2015,115_003,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - other human delay (go to section),No,No,9,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,8,11,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,25,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Yes - as an attachment,Secondary infection delay from symptom onset to lab confirmation.,11,5,2015,24,6,2015,115_005,MERS-CoV,1,0
115,1,FALSE,1973,Alba Halliday,Human delay - other human delay (go to section),No,No,4,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,CI95%,3,6,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,11,Hospital based,Persons under investigation,NA,NA,Republic of Korea,Pyeongtaek,City,Mid outbreak,Unspecified,Yes - as an attachment,Tertiary infection delay from symptom onset to lab confirmation.,11,5,2015,24,6,2015,115_007,MERS-CoV,1,0
76,1,FALSE,1981,Anne Cori,Human delay - time in care (length of stay),No,No,47,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,5,76.5,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,18,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,Hospital length of stay for severe cases NOT treated with ECMO (non-ECMO control group),NA,4,2014,NA,12,2015,076_007,MERS-CoV,1,0
73,1,FALSE,1981,David Jorgensen,Human delay - other human delay (go to section),No,No,7,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,4.3,11.5,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ICU admission,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,18,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,ICU length of stay for severe cases NOT treated with ECMO (non-ECMO control group),NA,4,2014,NA,12,2015,073_003,MERS-CoV,1,0
73,1,FALSE,1981,David Jorgensen,Human delay - time in care (length of stay),No,No,25,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,6.3,56.5,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,17,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,Hospital length of stay for severe cases treated with ECMO (ECMO group),NA,4,2014,NA,12,2015,073_004,MERS-CoV,1,0
73,1,FALSE,1981,David Jorgensen,Human delay - other human delay (go to section),No,No,22.5,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,12.5,28.3,NA,NA,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,ICU admission,Discharge from Critical Care/ICU,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,17,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,ICU length of stay for severe cases treated with ECMO (ECMO group),NA,4,2014,NA,12,2015,073_006,MERS-CoV,1,0
76,1,FALSE,1981,Anne Cori,Severity - case fatality rate (CFR),No,No,64.7,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,17,Unspecified,Other,NA,NA,NA,NA,NA,NA,NA,NA,Both,17,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,"Cases were severe cases in ICU, treated with ECMO (see article for eligibility criteria)",NA,4,2014,NA,12,2015,076_001,MERS-CoV,1,0
76,1,FALSE,1981,Anne Cori,Severity - case fatality rate (CFR),No,No,100,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,18,Unspecified,Clinically diagnosed/symptomatic,NA,NA,NA,NA,NA,NA,NA,NA,Both,18,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,"Cases were severe cases in ICU, NOT treated with ECMO (see article for eligibility criteria)",NA,4,2014,NA,12,2015,076_002,MERS-CoV,1,0
76,1,FALSE,1981,Anne Cori,Risk factors,No,No,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,NA,Significant,Not adjusted,NA,NA,NA,Both,35,Hospital based,Persons with symptoms,NA,NA,Saudi Arabia,NA,NA,Unspecified,Urban area,NA,other = treatment with ECMO for severe cases in ICU,NA,4,2014,NA,12,2015,076_003,MERS-CoV,1,0
77,1,FALSE,1985,Anne Cori,Severity - proportion of symptomatic cases,NA,NA,80,NA,NA,NA,NA,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,81,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh,NA,Unspecified,NA,Not available,NA,1,4,2014,30,9,2015,077_001,MERS-CoV,1,0
77,1,FALSE,1985,Anne Cori,Severity - case fatality rate (CFR),NA,NA,10,NA,NA,NA,NA,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,81,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh,NA,Unspecified,NA,Not available,'Around 10%',1,4,2014,30,9,2015,077_002,MERS-CoV,1,0
77,1,FALSE,1985,Anne Cori,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,Other,NA,Significant,Unspecified,No,NA,NA,Both,81,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,"Prince Mohammed bin Abdulaziz Hospital Emergency Department, Riyadh",hospital,Unspecified,Unspecified,Not available,"Matched case-control study, matching by age, sex, and presence of comorbidities. Outcome was positive test for mers-cov (among patients symptomatic with ILI). The significant risk factors identified were: any symptoms, white blood cell count, neutrophils, aspartame aminotransferase concentration, alanine aminotransferase concentration",1,4,2014,30,9,2015,077_003,MERS-CoV,1,0
77,1,FALSE,1985,Anne Cori,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Occupation,Other",NA,Not significant,Unspecified,No,NA,NA,Both,81,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,"Prince Mohammed bin Abdulaziz Hospital Emergency Department, Riyadh",hospital,Unspecified,Unspecified,Not available,"Matched case-control study, matching by age, sex, and presence of comorbidities. Outcome was positive test for mers-cov (among patients symptomatic with ILI). The non-significant risk factors identified were: Saudi nationality, Health care worker, any specific symptoms (GI, sore throat, fever, cough, shortness of breath), abnormal chest x-ray, lab results including hemoglobin, platelets, albumin, creatinine, admission to ICU, and mortality",1,4,2014,30,9,2015,077_004,MERS-CoV,1,0
23,1,FALSE,2007,Thomas Rawson,"Reproduction number (Effective, Re)",No,No,NA,NA,0,1.9,No,NA,NA,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Disease generation,Unspecified,681,Population based,General population,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - as an attachment,"R estimates provided broken down by 'within-cluster', 'within-region', and 'between region'. These can be combined to form effective R, but we only have the min/max of this range",1,1,2013,31,7,2014,023_001,MERS-CoV,1,0
23,1,FALSE,2007,Thomas Rawson,Human delay - serial interval,No,No,6.8,0,NA,NA,No,Days,Mean,Estimated parameter,NA,NA,CI95%,6,7.8,NA,NA,NA,NA,NA,NA,NA,Yes,Standard Deviation,4.1,NA,NA,NA,No,Days,No,Estimated parameter,NA,NA,CI95%,3.4,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,681,Unspecified,General population,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - as an attachment,NA,1,1,2013,31,7,2014,023_002,MERS-CoV,1,0
23,1,FALSE,2007,Thomas Rawson,Relative contribution - zoonotic to human,No,No,12,NA,NA,NA,No,Percentage (%),Unspecified,Estimated parameter,NA,NA,CI95%,9,15,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,681,Unspecified,General population,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - as an attachment,NA,1,1,2013,31,7,2014,023_003,MERS-CoV,1,0
23,1,FALSE,2007,Thomas Rawson,Relative contribution - human to human,No,No,88,NA,NA,NA,No,Percentage (%),Unspecified,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,681,Unspecified,General population,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - as an attachment,NA,1,1,2013,31,7,2014,023_004,MERS-CoV,1,0
28,1,FALSE,2011,Thomas Rawson,Severity - case fatality rate (CFR),No,No,20,0,NA,NA,No,Percentage (%),Maximum likelihood,Estimated parameter,NA,NA,CI95%,14.6,26.2,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,"Age,Time",Unspecified,185,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,Unspecified,Unspecified,Not available,The CFR estimate was adjusted for the time delay from illness onset to death using an integral equation model cited from previous studies.,NA,5,2015,31,7,2015,028_001,MERS-CoV,1,0
28,1,FALSE,2011,Thomas Rawson,Severity - case fatality rate (CFR),No,No,39.5,NA,NA,NA,No,Percentage (%),Maximum likelihood,Estimated parameter,NA,NA,CI95%,28.9,51,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,Population based,General population,60,NA,Republic of Korea,NA,NA,Unspecified,Unspecified,Not available,NA,NA,5,2015,31,7,2015,028_002,MERS-CoV,1,0
28,1,FALSE,2011,Thomas Rawson,Severity - case fatality rate (CFR),No,No,6.6,NA,NA,NA,No,Percentage (%),Maximum likelihood,Estimated parameter,NA,NA,CI95%,2.9,12.4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,Population based,General population,0,59,Republic of Korea,NA,NA,Unspecified,Unspecified,Not available,NA,NA,5,2015,31,7,2015,028_003,MERS-CoV,1,0
32,1,FALSE,2020,Thomas Rawson,Human delay - incubation period,No,No,8.19,NA,NA,NA,No,Unspecified,Mean,Estimated parameter,NA,NA,CI95%,5.49,11.66,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,"Gamma distribution (Shape = 4.44, rate =0.55) is the best fitted gamma distribution as seen in Figure A1 in Appendix S1, but it is the same as prior and not shown in Table 1 so I did not extract them above.",11,5,2015,NA,NA,2015,032_001,MERS-CoV,1,0
32,1,FALSE,2020,Thomas Rawson,Human delay - other human delay (go to section),No,No,9.26,NA,NA,NA,No,Days,Unspecified,Estimated parameter,NA,NA,CI95%,4.25,18.03,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,NA,11,5,2015,28,5,2015,032_002,MERS-CoV,1,0
32,1,FALSE,2020,Thomas Rawson,Human delay - other human delay (go to section),No,No,4.05,NA,NA,NA,No,Days,Unspecified,Estimated parameter,NA,NA,CI95%,1.8,6.93,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom Onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,NA,28,5,2015,NA,NA,NA,032_003,MERS-CoV,1,0
32,1,FALSE,2020,Thomas Rawson,Human delay - serial interval,No,No,12.62,NA,NA,NA,No,Days,Mean,Estimated parameter,Posterior standard deviation (Sd),4.37,NA,NA,NA,Gamma,Shape,8.33,NA,NA,0.66,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,The Gamma distribution is estimate from transmission tree reconstructed by the method of Hens el al. (see foot note a of Table 1).,11,5,2015,NA,NA,NA,032_004,MERS-CoV,1,0
32,1,FALSE,2020,Thomas Rawson,"Reproduction number (Effective, Re)",No,No,NA,NA,6.23,6.38,No,No units,Median,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Renewal equations / Branching process,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Disease generation,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Mid outbreak,Unspecified,Not available,NA,2,6,2015,2,6,2015,032_006,MERS-CoV,1,0
129,1,FALSE,2020,Hailin Feng,Reproduction number (Basic R0),No,No,9.11,NA,NA,NA,No,No units,Mean,Estimated parameter,NA,NA,CI95%,5.32,15.92,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,This is the REIC model estimate of basic reproduction number before effective intervention,11,5,2015,NA,NA,2015,129_001,MERS-CoV,1,0
129,1,FALSE,2020,Hailin Feng,Reproduction number (Basic R0),No,No,NA,NA,2.45,7.15,No,No units,Mean,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,This is the basic reproductive number estimated by 6 different statistical methods (using packages coded in R),11,5,2015,NA,NA,2015,129_002,MERS-CoV,1,0
129,1,FALSE,2020,Hailin Feng,"Reproduction number (Effective, Re)",No,No,0.368,NA,NA,NA,No,No units,Mean,Estimated parameter,NA,NA,CI95%,0.251,0.508,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,NA,Unspecified,Not available,The is the REIC model estimated reproductive number after effective intervention,11,5,2015,NA,NA,2015,129_003,MERS-CoV,1,0
129,1,FALSE,2020,Hailin Feng,Human delay - other human delay (go to section),No,Yes,6.83,NA,NA,NA,No,Days,Mean,Observed sample statistic,NA,NA,NA,NA,NA,Gamma,Shape,3.28,NA,NA,0.48,NA,Yes,Standard Deviation,3.77,NA,NA,NA,No,Days,Yes,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Symptom onset,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Time,Unspecified,186,Hospital based,General population,NA,NA,Republic of Korea,NA,Country,Unspecified,Unspecified,Not available,The scale parameter of the Gamma distribution extracted above is computed as 1/0.48 (1/rate) from Table 1 prior and Figure A2 from Supplement S1. The estimates of delay from symptom onset to confirmation disaggregatedd by breaking point (28-05-2015) is also available in Table 1.,20,5,2015,NA,7,2015,129_005,MERS-CoV,1,0
33,1,FALSE,2046,Thomas Rawson,Seroprevalence - Unspecified,No,No,24,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,17,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,Region,Unspecified,17,Hospital based,Healthcare workers,NA,NA,Saudi Arabia,Riyadh,NA,Unspecified,Unspecified,Not available,"This is seropositivity of HCWs who tested positive by PCR, around 2 months after such a test.",28,5,2017,19,6,2017,033_001,MERS-CoV,1,0
33,1,FALSE,2046,Thomas Rawson,Seroprevalence - Unspecified,No,No,3,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,114,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,114,Contact based,Persons under investigation,NA,NA,Saudi Arabia,Riyadh,NA,Unspecified,Unspecified,Not available,Contacts of HCWs who tested positive for MERS.,28,5,2017,19,6,2017,033_002,MERS-CoV,1,0
117,1,FALSE,2047,Ruth McCabe,Severity - case fatality rate (CFR),No,No,36.5,0,36,62,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,93,255,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,"Level of exposure,Other",Both,255,Hospital based,Persons under investigation,0,94,Saudi Arabia,Jeddah,'region',NA,Urban area,Unspecified,"Disaggregation across groups: all symptomatic non-HCWs; then split whether they could assess their data which then also includes another subset of primary or non-primary case. Potential primary case not included in range because <10 cases. Although described as a CFR in the paper, this is really an IFR - it includes infections reported as asymptomatic",1,1,2014,16,5,2014,117_001,MERS-CoV,1,0
117,1,FALSE,2047,Ruth McCabe,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Other,NA,Significant,Not adjusted,NA,NA,NA,Unspecified,255,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Jeddah,'region',NA,Urban area,Unspecified,'Patients who were contacted by telephone and for whom potential exposures were assessed were significantly more likely to have been admitted to an ICU than those for whom we could not assess exposure (P<0.001)',1,1,2014,16,5,2014,117_003,MERS-CoV,1,0
117,1,FALSE,2047,Ruth McCabe,Human delay - other human delay (go to section),No,No,11,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,7,23,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Admission to care,Symptom Onset/Fever,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,37,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,Jeddah,'region',NA,Urban area,Unspecified,"'Among the 37 admissions to a health care facility during the 14 days preceding the onset of illness, the median interval between admission and the onset of MERS-CoV symptoms was 11 days (interquartile range, 7 to 23).'",1,1,2014,16,5,2014,117_004,MERS-CoV,1,0
153,1,FALSE,2047,Kieran Chopra,Severity - proportion of asymptomatic cases,No,No,25.1,0,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,64,255,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,NA,NA,NA,Both,255,Hospital based,Persons under investigation,0,94,Saudi Arabia,Jeddah,'region',NA,Urban area,Unspecified,Some patients identified as asymptomatic did report symptoms before/after PCR testing upon further interview,1,1,2014,16,5,2014,153_002,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Severity - case fatality rate (CFR),No,No,33,0,1.3,94.6,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,317,959,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,"Occupation,Sex,Other",Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,Disaggregation: presence of & number of comorbidities; animal contact; camel contact; HCW; level of severity; place of transmission; secondary contact,6,6,2012,17,7,2015,118_001,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Severity - proportion of asymptomatic cases,No,No,15.8,NA,NA,NA,NA,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,NA,6,6,2012,17,7,2015,118_002,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Occupation,Other",Healthcare,Significant,Not adjusted,No,NA,NA,Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,Other riskfactors: presence of and number of comorbidities; HCW; disease severity; place of transmission; secondary contact,6,6,2012,17,7,2015,118_003,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Contact with animal,Sex,Camel contact (other)",NA,Not significant,Not adjusted,No,NA,NA,Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,NA,6,6,2012,17,7,2015,118_004,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Comorbidity,Occupation,Other",Healthcare,Significant,Adjusted,NA,NA,NA,Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,Other riskfactors: severity of illness,6,6,2012,17,7,2015,118_005,MERS-CoV,1,0
118,1,FALSE,2049,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Contact with animal,Sex,Camel contact (other),Other",NA,Not significant,Adjusted,No,NA,NA,Both,959,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,Other riskfactors: secondary contact,6,6,2012,17,7,2015,118_006,MERS-CoV,1,0
103,1,FALSE,2050,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Comorbidity,Non-household contact,Camel contact (other),Other",NA,Significant,Not adjusted,No,NA,NA,Both,360,Hospital based,Persons with symptoms,16,109,Saudi Arabia,King Abdulaziz Medical City in Riyadh (KAMCR) and King Fahad General Hospital in Jeddah (KFGH-JED),"Hospital, City",Unspecified,Urban area,Not available,Other risk factors - severe illness; 'sick patient or camel contact'; diabetes; heart disease; renal disease; WBC count; platelets; creatinine; bilirubin; AST; Albumin. Risk is among patients with pneumonia.,1,9,2012,1,6,2016,103_001,MERS-CoV,1,0
103,1,FALSE,2050,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Age,Comorbidity,Sex,Other",NA,Not significant,Not adjusted,No,NA,NA,Both,360,Hospital based,Persons with symptoms,16,109,Saudi Arabia,King Abdulaziz Medical City in Riyadh (KAMCR) and King Fahad General Hospital in Jeddah (KFGH-JED),"Hospital, City",Unspecified,Urban area,Not available,Other riskfactors: fever; respiratory symptoms; gastrointestinal symptoms; lung disease; liver disease; ALT. Risk is of infection among patients with pneumonia,1,9,2012,1,6,2016,103_002,MERS-CoV,1,0
103,1,FALSE,2050,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Comorbidity,Non-household contact,Sex,Camel contact (other),Other",NA,Significant,Adjusted,NA,NA,NA,Both,360,Hospital based,Persons with symptoms,16,109,Saudi Arabia,King Abdulaziz Medical City in Riyadh (KAMCR) and King Fahad General Hospital in Jeddah (KFGH-JED),"Hospital, City",Unspecified,Urban area,Not available,Other riskfactors - 'sick patient or camel contact'; diabetes; severe illness; WBC count; AST; ALT. Risk is of infection among patients with pneumonia. Risk prediction model using stepwise binary logistic regression - I think this is therefore adjusted,1,9,2012,1,6,2016,103_003,MERS-CoV,1,0
119,1,FALSE,2058,Hailin Feng,Seroprevalence - PRNT,No,No,0,NA,0,0,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,191,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,"Level of exposure,Occupation",Unspecified,191,Mixed settings,Mixed groups,NA,NA,Saudi Arabia,Al Hasa,NA,Unspecified,Unspecified,Unspecified,191 persons are categorized into 5 groups according to their occupational exposure. Information of whether using personal protective equipment is available for each group as well. Mixed settings/groups - herdsmen; animal carers; abattoir workers; vets; not exposed through work,NA,12,2013,NA,2,2014,119_001,MERS-CoV,1,0
84,1,FALSE,2067,Victoria Cox,Human delay - incubation period,No,No,6,NA,NA,NA,No,Days,Median,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,14,0,No,Days,No,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,NA,Hospital based,Persons under investigation,NA,NA,"Republic of Korea,Saudi Arabia",Riyadh; Jeddah; RoK overall; Pyeongtaek St Mary's Hospital; Samsung Seoul Hospital,NA,Unspecified,Unspecified,Yes - on another platform,Unclear how the incubation period is calculated; written in the discussion only,20,3,2014,4,7,2015,084_004,MERS-CoV,1,0
120,1,FALSE,2067,Ruth McCabe,Reproduction number (Basic R0),No,No,NA,NA,1.9168,8.1151,No,No units,Unspecified,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Unspecified,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,"Method,Region",Unspecified,NA,Hospital based,Persons under investigation,NA,NA,"Republic of Korea,Saudi Arabia",Riyadh; Jeddah; RoK overall; Pyeongtaek St Mary's Hospital; Samsung Seoul Hospital,NA,Unspecified,Unspecified,Yes - on another platform,R0 estimated for 5 locations under 3 different values of the serial interval,20,3,2014,4,7,2015,120_001,MERS-CoV,1,0
39,1,FALSE,2073,Christian Morgenstern,Human delay - other human delay (go to section),No,No,0.026122,NA,NA,NA,Yes,Days,Other,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,Infection,Recovery/non-Infectiousness,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,138,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,NA,NA,Yes - as an attachment,NA,20,5,2015,12,6,2015,039_002,MERS-CoV,1,0
128,1,FALSE,2073,Alba Halliday,Reproduction number (Basic R0),No,No,8.0977,NA,NA,NA,No,No units,Other,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Compartmental model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,138,Unspecified,Unspecified,NA,NA,Republic of Korea,NA,NA,NA,Unspecified,Yes - on another platform,Minimise the sum of the squared errors solved numerically. End date chosen under assumption incubation period is 5 days - interventions stated on 07-06-2015.,20,5,2015,12,6,2015,128_001,MERS-CoV,1,0
132,1,FALSE,2079,David Jorgensen,Seroprevalence - PRNT,No,No,0,NA,NA,NA,NA,Percentage (%),Other,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,350,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,NA,NA,NA,Both,350,Mixed settings,Mixed groups,15,84,Saudi Arabia,Jazan region,region,Unspecified,Unspecified,NA,Animal exposed individuals and controls but no positives,NA,7,2012,NA,7,2012,132_001,MERS-CoV,1,0
41,1,FALSE,2091,Christian Morgenstern,Seroprevalence - IgG,No,NA,NA,NA,NA,NA,No,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,2409,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,2409,Population based,General population,16,NA,Pakistan,"Punjab, Khyber Pakhtunkhwa, Balochistan, Sindh",Provinces,NA,Both urban and rural areas,Not available,"human serum samples were obtained from hospitals, primary health care centres and blood banks. Serological test for anti-MERS-CoV IgG rELISA.",NA,NA,2016,NA,NA,2017,041_001,MERS-CoV,1,0
41,1,FALSE,2091,Christian Morgenstern,Seroprevalence - PRNT,No,No,0,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,91,Adjusted,Lab confirmed,NA,NA,NA,NA,NA,NA,NA,NA,Both,2409,Population based,General population,16,NA,Pakistan,"Punjab, Khyber Pakhtunkhwa, Balochistan, Sindh",Provinces,NA,Both urban and rural areas,Not available,"of the 2409 serum samples analysed, 91 tested above a certain threshold on an IgG Elisa, and these 91 were further investigated with a microneutralization assay, the results of which are reported here",NA,NA,2016,NA,NA,2017,041_002,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Severity - proportion of symptomatic cases,No,No,90.4,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,"WHO case report database, data also available from author",5,1,2015,10,3,2017,157_001,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Relative contribution - zoonotic to human,No,No,22.1,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,"Data available from author, but used WHO public data anyway",5,1,2015,10,3,2017,157_002,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Sex,NA,Not significant,Not adjusted,No,NA,NA,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,3-6 are 14-day mortality,5,1,2015,10,3,2017,157_003,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Occupation,Other",Healthcare,Significant,Not adjusted,Yes,No,Region,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,"Other: includes Source of infection, symptomatic, and region. Source of infection disaggregates into levels Household, Camels (unspecified route), Healthcare. Have not ticked household/non household contact as a separate factor, or camels categories",5,1,2015,10,3,2017,157_004,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Other",NA,Not significant,Adjusted,Yes,Yes,Age,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,Other here includes Symptomatic status.,5,1,2015,10,3,2017,157_005,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Comorbidity,Occupation,Other",Healthcare,Not significant,Adjusted,Yes,No,Region,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,Other here includes Source of infection and Region. See parameter 4 notes.,5,1,2015,10,3,2017,157_006,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Sex,NA,Not significant,Not adjusted,No,NA,NA,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,7-10 are 45-day mortality risk.,5,1,2015,10,3,2017,157_007,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Occupation,Other",Healthcare,Significant,Not adjusted,Yes,Yes,Region,Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,"Other here includes: Source infection (including unspecified camel route), Symptomatic, region.",5,1,2015,10,3,2017,157_008,MERS-CoV,1,0
157,1,FALSE,2105,Julia Halder,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Occupation,Other",Healthcare,Significant,Adjusted,Yes,NA,"Age,Region,Other",Both,883,Mixed settings,Mixed groups,2,109,NA,Worldwide,NA,Mid outbreak,Unspecified,Yes - on another platform,"Other includes: Region, Symptomatic, Source of infection (including unspecified camel routes)",5,1,2015,10,3,2017,157_009,MERS-CoV,1,0
44,1,FALSE,2109,Thomas Rawson,Seroprevalence - Unspecified,No,No,54,0,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,24,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,No,Symptoms,Both,24,Hospital based,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,emirate,Mid outbreak,Both urban and rural areas,Not available,"These were confirmed MERS cases followed up ~2 months later. Sero positive if positive in 2 of 3 different sero tests conducted. The 54% is the seroprevalence among case patients. Defination of seropositive: MERS-CoV antibody positivity was defined as one of the following: (1) 2 of 3 tests (ie, MERS-CoV nucleocapsid ELISA, MERS-CoV MNT, and IFA) were positive; or (2) MERS Co-V MNT was the only positive test.",NA,5,2014,NA,6,2014,044_001,MERS-CoV,1,0
44,1,FALSE,2109,Thomas Rawson,Seroprevalence - Unspecified,No,No,0,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,124,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,105,Household based,Household contacts of survivors,NA,NA,United Arab Emirates,Abu Dhabi,emirate,Mid outbreak,Both urban and rural areas,Not available,Household contacts of confirmed cases. Sero positive if positive in at least 2 of 3 sero tests performed.,NA,5,2014,NA,6,2014,044_002,MERS-CoV,1,0
44,1,FALSE,2109,Thomas Rawson,Human delay - time in care (length of stay),No,No,19,NA,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,12,26,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,No,Symptoms,Both,34,Hospital based,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,emirate,Mid outbreak,Both urban and rural areas,Not available,NA,NA,5,2014,NA,6,2014,044_003,MERS-CoV,1,0
44,1,FALSE,2109,Thomas Rawson,Severity - proportion of asymptomatic cases,No,No,50,0,NA,NA,NA,Percentage (%),Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,34,Naive,NA,NA,NA,NA,NA,NA,Yes,No,"Age,Level of exposure,Region,Sex,Time,Other",Both,34,Hospital based,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,emirate,Mid outbreak,Both urban and rural areas,Not available,NA,NA,5,2014,NA,6,2014,044_004,MERS-CoV,1,0
148,1,FALSE,2109,Yiran Wang,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Serology,"Age,Other",NA,Significant,Not adjusted,No,NA,NA,Both,24,Hospital based,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,Emirate,Mid outbreak,Both urban and rural areas,Not available,"setting & group: lab-confirmed cases and their household contacts, so i consider mixed setting & group? risk factors for case patients to test seropositive: age, days of PCR positivity, No. of days being PCR positive, and disease severity. Used chi-squared test so unadjusted. I am a bit confused about the start & end date, in the method it said cases diagnosed between 2013-2014 were enrolled, but in discussion it said that this investigation occurred during May-June 2014.",NA,5,2014,NA,6,2014,148_001,MERS-CoV,1,0
148,1,FALSE,2109,Yiran Wang,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Serology,"Sex,Other",NA,Not significant,Not adjusted,No,NA,NA,Both,24,Hospital based,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,Emirate,Mid outbreak,Both urban and rural areas,Not available,"risk factor for testing seropositive among MERS case patients, extracted from table 4, sex, nationality, region, duration of stay in same house as a MERS-Cov case, duration since last PCR-positive test, insignificant",NA,5,2014,NA,6,2014,148_004,MERS-CoV,1,0
148,1,FALSE,2109,Yiran Wang,Human delay - other human delay (go to section),No,No,55,0,NA,NA,No,Days,Median,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,IQR,NA,53,58,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,the first PCR-positive result,Other,have detectable MERS-CoV antibodies,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,24,Mixed settings,Persons under investigation,NA,NA,United Arab Emirates,Abu Dhabi,Emirate,Mid outbreak,Both urban and rural areas,Not available,NA,NA,5,2014,NA,6,2014,148_005,MERS-CoV,1,0
46,1,FALSE,2116,Thomas Rawson,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Infection,"Environmental,Temperature,Humidity",NA,Significant,Not adjusted,No,NA,NA,Both,446,Population based,NA,15,98,Saudi Arabia,NA,NA,Unspecified,Unspecified,Yes - on another platform,Case-crossover analysis of meteorological variables and cases over time. All analysis were conducted on primary MERS cases filtered from WHO publicly available data. Environmental variables included in the univariable conditional; logistic regression but not listed are wind speed and visibility. All analysis considered time-lags (within the incubation period of 2-14 days).,NA,1,2015,NA,12,2017,046_001,MERS-CoV,1,0
52,1,FALSE,2136,Thomas Rawson,Human delay - other human delay (go to section),Yes,No,19.86,0,NA,NA,No,Days,Unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Unspecified (paired),NA,16.95,22.71,0,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Positive PCR test,Recovery/non-Infectiousness,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,53,Hospital based,General population,NA,NA,Saudi Arabia,King Abdulaziz Medical City in Riyadh (KAMC-R) and King Fahd General Hospital in Jeddah (KFGH-JED).,Hospitals,Unspecified,Unspecified,Not available,Eyeballed from figure,NA,9,2012,NA,6,2016,052_001,MERS-CoV,1,0
53,1,FALSE,2140,Thomas Rawson,Severity - proportion of symptomatic cases,No,No,81,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,16,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,16,Hospital based,General population,0,78,Jordan,NA,Hospitals,Unspecified,Unspecified,Not available,NA,NA,8,2015,NA,10,2015,053_001,MERS-CoV,1,0
53,1,FALSE,2140,Thomas Rawson,Severity - case fatality rate (CFR),No,No,44,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,16,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,16,Hospital based,General population,0,78,Jordan,NA,Hospitals,Unspecified,Unspecified,Not available,NA,NA,8,2015,NA,10,2015,053_002,MERS-CoV,1,0
130,1,FALSE,2140,Kieran Chopra,Seroprevalence - Unspecified,No,No,9,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,23,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,23,Household based,Household contacts of survivors,NA,NA,Jordan,NA,NA,NA,Unspecified,Not available,Seropositive if positive in 2 of 3 different sero tests; seroprevalence of household contacts of confirmed cases; Supplementary tables provide some more specific sero info.,NA,3,2016,NA,4,2016,130_002,MERS-CoV,1,0
130,1,FALSE,2140,Kieran Chopra,Seroprevalence - Unspecified,No,No,1,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,278,Naive,Lab confirmed,NA,NA,NA,NA,NA,Yes,Yes,Level of exposure,Unspecified,278,Hospital based,Healthcare workers,NA,NA,Jordan,NA,Hospitals,NA,Unspecified,Not available,Seropositive if positive in 2 of 3 different sero tests; seroprevalence of household contacts of confirmed cases; Supplementary tables provide some more specific sero info.,NA,3,2016,NA,4,2016,130_001,MERS-CoV,1,0
71,1,FALSE,2141,Thomas Rawson,Seroprevalence - Unspecified,No,No,0,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,61,Naive,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,61,Mixed settings,Mixed groups,NA,NA,United States of America,Indiana,NA,Unspecified,Unspecified,Not available,Serology of close contacts - mostly HCWs. Positive serology if positve in at least 2 of three different serology tests.,NA,4,2014,NA,5,2014,071_001,MERS-CoV,1,0
166,1,FALSE,2144,Gina Cuomo-Dannenburg,Risk factors,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Age,Close contact,Sex,Camel contact (other),Other",Unspecified,Significant,Adjusted,NA,NA,NA,Unspecified,36,Mixed settings,Persons under investigation,NA,NA,NA,NA,NA,NA,Unspecified,Yes - on another platform,"Data was made available but link has expired. Therefore, do not know what country the cases come from but is all the global cases on the WHO repo within those dates inclusive. Assessed whether the factors has an effect on the regression they used to analyse. A bit confused if this even counts as a risk factor?? And in terms of risk outcome, I think it is the # of cases globally but it's very unclear; Other - Region (middle east), country KSA an exposure to MERS-CoV cases also found significant",NA,1,2015,8,1,2018,166_001,MERS-CoV,1,0
166,1,FALSE,2144,Gina Cuomo-Dannenburg,Risk factors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,"Comorbidity,Occupation",Healthcare,Not significant,Adjusted,NA,NA,NA,Unspecified,36,Mixed settings,Persons under investigation,NA,NA,NA,NA,NA,NA,Unspecified,Yes - on another platform,"Data was made available but link has expired. Therefore, do not know what country the cases come from but is all the global cases on the WHO repo within those dates inclusive. Assessed whether the factors has an effect on the regression they used to analyse. A bit confused if this even counts as a risk factor?? And in terms of risk outcome, I think it is the # of cases globally but it's very unclear; Other - Region (middle east), country KSA an exposure to MERS-CoV cases also found significant",NA,1,2015,8,1,2018,166_002,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Severity - case fatality rate (CFR),No,No,7.03,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,128,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,128,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,NA,1,4,2012,7,7,2015,048_001,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - incubation period,No,No,5,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,2,15,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,92,Hospital based,Persons under investigation,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,"non-healthcare works, sample size overall 92 but unclear how many included in delay",1,4,2012,7,7,2015,048_011,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Severity - proportion of asymptomatic cases,No,No,36.72,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,128,NA,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,128,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,NA,1,4,2012,7,7,2015,048_002,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>admission to care,No,No,5,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,14,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,92,Hospital based,Persons under investigation,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,"non-healthcare works, sample size overall 92 but unclear how many included in delay",1,4,2012,7,7,2015,048_012,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - incubation period,No,No,7,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,128,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size of incubation period,1,4,2012,7,7,2015,048_003,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>death,No,No,12,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,52,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,34,Hospital based,Persons under investigation,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,"non-healthcare works, sample size overall 92 but unclear how many included in delay",1,4,2012,7,7,2015,048_013,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>admission to care,No,No,5,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,0,11,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,128,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size for this delay is,1,4,2012,7,7,2015,048_004,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>discharge/recovery,No,No,12,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,30,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,58,Hospital based,Persons under investigation,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,"non-healthcare works, sample size overall 92 but unclear how many included in delay",1,4,2012,7,7,2015,048_014,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - other human delay (go to section),No,No,6,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,14,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,128,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size for this delay is,1,4,2012,7,7,2015,048_005,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - other human delay (go to section),No,No,10,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,1,21,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Onset of symptoms,Diagnosis/test result,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,92,Hospital based,Persons under investigation,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,"non-healthcare works, sample size overall 92 but unclear how many included in delay",1,4,2012,7,7,2015,048_015,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>death,No,No,13,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,4,17,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,9,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size for this delay is,1,4,2012,7,7,2015,048_006,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Severity - case fatality rate (CFR),No,No,35.6,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,487,1368,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,1368,Hospital based,Persons under investigation,2,90,NA,NA,NA,NA,NA,Not available,CFR based on global cases up to 7 July 2015,NA,NA,NA,7,7,2015,048_016,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - symptom onset>discharge/recovery,No,No,11,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,5,24,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,119,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size for this delay is,1,4,2012,7,7,2015,048_007,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Risk factors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Occupation,Healthcare,Significant,Unspecified,NA,NA,NA,Both,220,Hospital based,Mixed groups,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,NA,1,4,2012,7,7,2015,048_017,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Human delay - time in care (length of stay),No,No,9.5,NA,NA,NA,No,Days,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Range,NA,3,22,NA,No,Days,No,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Both,220,Hospital based,Healthcare workers,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Overall 128 HCW but unclear what sample size for this delay is,1,4,2012,7,7,2015,048_008,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Severity - case fatality rate (CFR),No,No,36.96,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,34,92,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,92,Hospital based,Persons with symptoms,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Cases in non-healthcare workers,1,4,2012,7,7,2015,048_009,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Risk factors,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Other,Occupation,Healthcare,Significant,Unspecified,NA,NA,NA,Both,220,Hospital based,Mixed groups,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Risk of asymptomatic disease,1,4,2012,7,7,2015,048_019,MERS-CoV,1,0
48,1,FALSE,2185,Christian Morgenstern,Severity - proportion of asymptomatic cases,No,No,17.39,NA,NA,NA,No,Percentage (%),NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,92,NA,Lab confirmed,NA,NA,NA,NA,NA,No,NA,NA,Both,92,Hospital based,Persons with symptoms,NA,NA,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,NA,NA,Not available,Cases in non-healthcare workers,1,4,2012,7,7,2015,048_010,MERS-CoV,1,0
70,1,FALSE,2185,Anh Pham,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),Occupation,Healthcare,Significant,Not adjusted,No,NA,NA,Both,183,Hospital based,Persons under investigation,2,90,"Iran (Islamic Republic of),Jordan,Philippines,Republic of Korea,Saudi Arabia,United Arab Emirates",NA,NA,Start outbreak,Unspecified,Yes - as an attachment,NA,1,4,2012,7,7,2015,070_002,MERS-CoV,1,0
125,1,FALSE,2186,Rhys Earl,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Hospitalisation,Sex,Camel contact (other),Other",Unspecified,Not significant,Not adjusted,NA,NA,NA,NA,1094,Community based,Persons under investigation,NA,NA,NA,NA,NA,Post outbreak,Unspecified,Yes - on another platform,"Other non-sign risk factors: Saudi nationality,Background of contact with morbid case at home or hospital 1-14 days prior to the onset of symptoms,  Need for admission to negative pressure isolation room or ICU, secondary case, other camel was conact with camel or camel milk 1-14 days prior",23,9,2012,11,11,2016,125_001,MERS-CoV,1,0
125,1,FALSE,2186,Rhys Earl,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,Unspecified,Significant,Not adjusted,Yes,No,Time,Both,1094,Community based,Persons under investigation,NA,NA,NA,NA,NA,Post outbreak,Unspecified,Yes - on another platform,"sig risk factors, Native morbid case, Travel History,- these are disaggregated by year 2013-2016",23,9,2012,11,11,2016,125_002,MERS-CoV,1,0
155,1,FALSE,2197,Gemma Nedjati-Gilani,Severity - case fatality rate (CFR),Yes,No,NA,NA,NA,NA,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Naive,Confirmed,NA,NA,NA,NA,NA,Yes,Yes,"Age,Region,Sex",Both,1372,Unspecified,Unspecified,0,109,"Republic of Korea,Saudi Arabia",NA,NA,Post outbreak,Unspecified,Yes - on another platform,"In figure 1C, CFRs broken down by age, sex and country",NA,6,2012,NA,12,2015,155_002,MERS-CoV,1,0
167,1,FALSE,2197,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,19.2,0,15.2,21.2,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,228,1186,Naive,Confirmed,NA,NA,NA,NA,NA,Yes,NA,Sex,Both,1299,NA,Persons under investigation,0,109,Saudi Arabia,NA,NA,NA,NA,NA,CFR for KSA outbreak compared. Range around central estimate is CFR broken down by sex,NA,6,2012,NA,12,2015,167_001,MERS-CoV,1,0
167,1,FALSE,2197,Gina Cuomo-Dannenburg,Severity - case fatality rate (CFR),No,No,19.4,0,15.8,21.8,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,36,186,Naive,Confirmed,NA,NA,NA,NA,NA,Yes,No,Sex,Both,186,NA,Persons under investigation,16,87,Republic of Korea,NA,NA,NA,NA,NA,CFR for KSA outbreak compared. Range around central estimate is CFR broken down by sex,NA,6,2012,NA,12,2015,167_002,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Severity - case fatality rate (CFR),No,No,37,NA,3.23,100,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Unspecified,Lab confirmed,NA,NA,NA,NA,NA,Yes,NA,"Age,Level of exposure,Occupation,Sex,Symptoms,Other",Both,51,Hospital based,Persons under investigation,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Not available,"Range taken from 'Death' column in Table 1, which includes mortality by many different symptoms, comorbidities and treatments given. The range was taken only for those with >10 obs in the subgroup.",NA,1,2014,NA,12,2014,113_001,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Occupation,Sex,Other",Healthcare,Significant,Not adjusted,NA,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other' risk factors: hypertension; vomiting; abnormal lung exam; respiratory rate; blood oxygen; oxygen saturation; hemoglobin; white blood cell count; AST; creatinine; negative repeat PCR swab; radiology; CXR; specific treatments administered including if admitted to ICU. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_002,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),"Age,Comorbidity,Other",NA,Not significant,Not adjusted,NA,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other' riskfactors: known MERS exposure; Umrah patient; diabetes; end stage renal disease; coronary artery disease; immunosuppression; runny nose; cough; diarrhea; sore throat; subjective fever; temperature; white blood cell count; platelets; ALT; LDH; CK; potassium;  specific treatments. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_003,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,NA,Significant,Adjusted,No,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other riskfactors: modified APACHE 2 score. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_004,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Death (in general population),Other,NA,Not significant,Adjusted,No,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other' riskfactors: specific treatments including beta interferon; alpha interferon; hydrocortisone; ribavirin. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_005,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),Other,NA,Significant,Not adjusted,No,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other' riskfactors: beta interferon; viral treatment; mycophenolate mofetil. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_006,MERS-CoV,1,0
113,1,FALSE,2212,Ruth McCabe,Risk factors,No,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Severe disease (in general population),Other,NA,Not significant,Not adjusted,NA,NA,NA,Both,51,Hospital based,Mixed groups,NA,NA,Saudi Arabia,King Fahd General Hospital; Jeddah,NA,Unspecified,Unspecified,Unspecified,Other' riskfactors: alpha interferon; ribavirin; hydrocortisone. Mixed groups - PUI & HCWs ,NA,1,2014,NA,12,2014,113_007,MERS-CoV,1,0
140,1,FALSE,2214,Haowei (Vivi) Wang,Reproduction number (Basic R0) - Human,Yes,No,NA,NA,1.117,4.944,No,NA,Mean,Estimated parameter,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Agent-based model,Human-human,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Yes,Yes,Method,Unspecified,186,Hospital based,Persons under investigation,NA,NA,Republic of Korea,NA,NA,NA,NA,NA,"The paper reports multiple mean R0 values from different agent-based model scenarios.  The reported range represents the minimum (1.117, from the model with no super-spreaders) and maximum (4.944) mean R0values across all tested scenarios.",NA,5,2015,NA,7,2015,140_001,MERS-CoV,1,0
158,1,FALSE,2215,Amy Dighe,Severity - case fatality rate (CFR),No,No,NA,NA,NA,NA,No,NA,NA,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,28,Adjusted,Confirmed,NA,NA,NA,NA,NA,No,NA,NA,Unspecified,28,Contact based,Persons under investigation,NA,NA,Republic of Korea,"Pyeongtaek; National Medical Center, Seoul, Korea","City; Hospital, City, Country",Mid outbreak,Unspecified,Not available,percentage or proportion not given. no statistical adjustments made but authors followed all cases until outcome was known.,20,5,2015,3,6,2015,158_001,MERS-CoV,1,0
102,1,FALSE,14039,Gemma Nedjati-Gilani,Seroprevalence - PRNT,No,No,NA,NA,67.7,100,No,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,38,49,Naive,NA,NA,NA,NA,NA,NA,Yes,No,"Symptoms,Time",Both,48,Hospital based,Persons under investigation,28,74,Saudi Arabia,Jeddah; Riyadh,NA,Post outbreak,Unspecified,Yes - as an attachment,These are from regional hospitals so patients might come from outside these two cities; Also there are 49 samples from 48 patients,NA,NA,NA,NA,NA,NA,102_001,MERS-CoV,1,0
135,1,FALSE,14039,Joseph Hicks,Seroprevalence - IgG,No,No,31,NA,NA,NA,Yes,Percentage (%),Central - unspecified,Observed sample statistic,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,38,Naive,NA,NA,NA,NA,NA,NA,No,NA,NA,Both,38,Hospital based,Mixed groups,NA,NA,Saudi Arabia,Jeddah; Riyadh,NA,Post outbreak,Unspecified,Yes - as an attachment,This is reported as the percentage of those who have neutralizing antibodies that are NEGATIVE for ELISA (why inverse box is ticked); Full results for IgG ELISA available on individual level in a table.,NA,NA,NA,NA,NA,NA,135_002,MERS-CoV,1,0
